HRP20150517T1 - Triazolopiridini - Google Patents
Triazolopiridini Download PDFInfo
- Publication number
- HRP20150517T1 HRP20150517T1 HRP20150517TT HRP20150517T HRP20150517T1 HR P20150517 T1 HRP20150517 T1 HR P20150517T1 HR P20150517T T HRP20150517T T HR P20150517TT HR P20150517 T HRP20150517 T HR P20150517T HR P20150517 T1 HRP20150517 T1 HR P20150517T1
- Authority
- HR
- Croatia
- Prior art keywords
- amino
- phenyl
- triazolo
- pyridin
- benzamide
- Prior art date
Links
- 150000008523 triazolopyridines Chemical class 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 39
- -1 hydroxy- Chemical class 0.000 claims 33
- 150000001875 compounds Chemical class 0.000 claims 31
- 125000005843 halogen group Chemical group 0.000 claims 21
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 17
- 150000003839 salts Chemical class 0.000 claims 13
- 125000001424 substituent group Chemical group 0.000 claims 13
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 12
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 10
- 150000001204 N-oxides Chemical class 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 9
- 239000012453 solvate Substances 0.000 claims 9
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 8
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 7
- 201000010099 disease Diseases 0.000 claims 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 7
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 6
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 230000024932 T cell mediated immunity Effects 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 6
- 230000010261 cell growth Effects 0.000 claims 6
- 230000004663 cell proliferation Effects 0.000 claims 6
- 230000001413 cellular effect Effects 0.000 claims 6
- 230000028709 inflammatory response Effects 0.000 claims 6
- 230000004083 survival effect Effects 0.000 claims 6
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 5
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 4
- 208000003174 Brain Neoplasms Diseases 0.000 claims 4
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims 4
- 206010027476 Metastases Diseases 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 3
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 2
- 125000004939 6-pyridyl group Chemical group N1=CC=CC=C1* 0.000 claims 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 claims 2
- 208000002699 Digestive System Neoplasms Diseases 0.000 claims 2
- 208000001976 Endocrine Gland Neoplasms Diseases 0.000 claims 2
- 208000009849 Female Genital Neoplasms Diseases 0.000 claims 2
- 206010025323 Lymphomas Diseases 0.000 claims 2
- 206010059282 Metastases to central nervous system Diseases 0.000 claims 2
- 201000003793 Myelodysplastic syndrome Diseases 0.000 claims 2
- 206010029098 Neoplasm skin Diseases 0.000 claims 2
- 229930012538 Paclitaxel Natural products 0.000 claims 2
- 208000000453 Skin Neoplasms Diseases 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 claims 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 238000005859 coupling reaction Methods 0.000 claims 2
- 201000011523 endocrine gland cancer Diseases 0.000 claims 2
- 125000001475 halogen functional group Chemical group 0.000 claims 2
- 208000014829 head and neck neoplasm Diseases 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 208000032839 leukemia Diseases 0.000 claims 2
- 208000037841 lung tumor Diseases 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 208000025426 neoplasm of thorax Diseases 0.000 claims 2
- 229960001592 paclitaxel Drugs 0.000 claims 2
- 210000002307 prostate Anatomy 0.000 claims 2
- 201000004477 skin sarcoma Diseases 0.000 claims 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 2
- 201000003957 thoracic cancer Diseases 0.000 claims 2
- 210000003932 urinary bladder Anatomy 0.000 claims 2
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 claims 1
- LKJPYSCBVHEWIU-KRWDZBQOSA-N (R)-bicalutamide Chemical compound C([C@@](O)(C)C(=O)NC=1C=C(C(C#N)=CC=1)C(F)(F)F)S(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-KRWDZBQOSA-N 0.000 claims 1
- MNIBFPYCGHZSJI-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-n-[4-[2-(2-methoxy-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]acetamide Chemical compound COC1=CC(S(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C(=CC(F)=CC=4)F)=CC=3)C=CC2=N1 MNIBFPYCGHZSJI-UHFFFAOYSA-N 0.000 claims 1
- YIRBGLAWGUIYAL-UHFFFAOYSA-N 2-(4-chlorophenyl)-n-[4-[2-(2-methoxy-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]acetamide Chemical compound COC1=CC(S(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(Cl)=CC=4)=CC=3)C=CC2=N1 YIRBGLAWGUIYAL-UHFFFAOYSA-N 0.000 claims 1
- DHSYBOMXQOPERQ-UHFFFAOYSA-N 2-(4-fluoro-3-methylphenyl)-n-[4-[2-(2-methoxy-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]acetamide Chemical compound COC1=CC(S(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=C(C)C(F)=CC=4)=CC=3)C=CC2=N1 DHSYBOMXQOPERQ-UHFFFAOYSA-N 0.000 claims 1
- FWNWOXNNGAKBKY-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[4-[2-(2-methoxy-4-methylsulfinylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]acetamide Chemical compound COC1=CC(S(C)=O)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 FWNWOXNNGAKBKY-UHFFFAOYSA-N 0.000 claims 1
- JJIYOPXGPPZANG-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[4-[2-(2-methyl-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]acetamide Chemical compound CC1=CC(S(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 JJIYOPXGPPZANG-UHFFFAOYSA-N 0.000 claims 1
- VUIAJHXSJSJPOW-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[4-[2-(4-methoxy-2-methylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]acetamide Chemical compound CC1=CC(OC)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 VUIAJHXSJSJPOW-UHFFFAOYSA-N 0.000 claims 1
- WUDPYZZMQYKTKW-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[4-[2-[2-methoxy-4-(methylsulfonimidoyl)anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]acetamide Chemical compound COC1=CC(S(C)(=N)=O)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 WUDPYZZMQYKTKW-UHFFFAOYSA-N 0.000 claims 1
- PBKTWEVEFXHQFA-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[4-[2-[4-(2-hydroxypropan-2-yl)-2-methoxyanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]acetamide Chemical compound COC1=CC(C(C)(C)O)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 PBKTWEVEFXHQFA-UHFFFAOYSA-N 0.000 claims 1
- UCFBXUOGFYVMQX-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[4-[2-[4-(hydroxymethyl)-2-methoxyanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]acetamide Chemical compound COC1=CC(CO)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 UCFBXUOGFYVMQX-UHFFFAOYSA-N 0.000 claims 1
- XOYXUGAXQFRVGX-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[4-[2-[4-(methanesulfonamido)-2-methylanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]acetamide Chemical compound CC1=CC(NS(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 XOYXUGAXQFRVGX-UHFFFAOYSA-N 0.000 claims 1
- PPDMEAQPDPHMON-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[4-[2-[4-methylsulfinyl-2-(2,2,2-trifluoroethoxy)anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]acetamide Chemical compound FC(F)(F)COC1=CC(S(=O)C)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 PPDMEAQPDPHMON-UHFFFAOYSA-N 0.000 claims 1
- ZJHXQWRONHCPSL-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-[4-[2-[4-methylsulfonyl-2-(2,2,2-trifluoroethoxy)anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]acetamide Chemical compound FC(F)(F)COC1=CC(S(=O)(=O)C)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 ZJHXQWRONHCPSL-UHFFFAOYSA-N 0.000 claims 1
- MVZPKURHXUQCGH-UHFFFAOYSA-N 2-chloro-n-[(4-fluorophenyl)methyl]-4-[2-[4-[(1-hydroxy-2-methylpropan-2-yl)carbamoyl]-2-methoxyanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]benzamide Chemical compound COC1=CC(C(=O)NC(C)(C)CO)=CC=C1NC1=NN2C=C(C=3C=C(Cl)C(C(=O)NCC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 MVZPKURHXUQCGH-UHFFFAOYSA-N 0.000 claims 1
- CECJCVOLFDPIIF-UHFFFAOYSA-N 3-(cyclopropylmethoxy)-n,n-diethyl-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]benzamide Chemical compound C1CC1COC1=CC(C(=O)N(CC)CC)=CC=C1NC(=NN1C=2)N=C1C=CC=2C(C=C1)=CC=C1NC(=O)CC1=CC=C(F)C=C1 CECJCVOLFDPIIF-UHFFFAOYSA-N 0.000 claims 1
- WCWGKNBVCRPASD-UHFFFAOYSA-N 3-ethoxy-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(1-hydroxy-2-methylpropan-2-yl)benzamide Chemical compound CCOC1=CC(C(=O)NC(C)(C)CO)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 WCWGKNBVCRPASD-UHFFFAOYSA-N 0.000 claims 1
- LTDODPNIHNMBSC-UHFFFAOYSA-N 3-ethoxy-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(2-hydroxy-2-methylpropyl)benzamide Chemical compound CCOC1=CC(C(=O)NCC(C)(C)O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 LTDODPNIHNMBSC-UHFFFAOYSA-N 0.000 claims 1
- BJELOFSVOCGXPY-UHFFFAOYSA-N 3-ethoxy-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(2-hydroxyethyl)-n-methylbenzamide Chemical compound CCOC1=CC(C(=O)N(C)CCO)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 BJELOFSVOCGXPY-UHFFFAOYSA-N 0.000 claims 1
- FAHIKABFXPEIHI-UHFFFAOYSA-N 3-ethoxy-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(2-hydroxyethyl)benzamide Chemical compound CCOC1=CC(C(=O)NCCO)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 FAHIKABFXPEIHI-UHFFFAOYSA-N 0.000 claims 1
- YCEYLSFCTPEHNG-UHFFFAOYSA-N 3-ethoxy-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(2-methylsulfonylethyl)benzamide Chemical compound CCOC1=CC(C(=O)NCCS(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 YCEYLSFCTPEHNG-UHFFFAOYSA-N 0.000 claims 1
- JMKKVQPGCAXZMB-UHFFFAOYSA-N 3-ethoxy-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(1-hydroxy-2-methylpropan-2-yl)benzamide Chemical compound CCOC1=CC(C(=O)NC(C)(C)CO)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 JMKKVQPGCAXZMB-UHFFFAOYSA-N 0.000 claims 1
- AJYPDBSIXHXNPU-UHFFFAOYSA-N 3-ethoxy-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(2-hydroxy-2-methylpropyl)benzamide Chemical compound CCOC1=CC(C(=O)NCC(C)(C)O)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 AJYPDBSIXHXNPU-UHFFFAOYSA-N 0.000 claims 1
- DMQSPAQNIBRPIY-UHFFFAOYSA-N 3-ethoxy-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(2-hydroxyethyl)-n-methylbenzamide Chemical compound CCOC1=CC(C(=O)N(C)CCO)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 DMQSPAQNIBRPIY-UHFFFAOYSA-N 0.000 claims 1
- GSYULZYCZBRKGK-UHFFFAOYSA-N 3-ethoxy-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(2-methylsulfonylethyl)benzamide Chemical compound CCOC1=CC(C(=O)NCCS(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 GSYULZYCZBRKGK-UHFFFAOYSA-N 0.000 claims 1
- PVUKIADHKKDSRF-UHFFFAOYSA-N 3-ethoxy-n,n-diethyl-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]benzamide Chemical compound CCOC1=CC(C(=O)N(CC)CC)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 PVUKIADHKKDSRF-UHFFFAOYSA-N 0.000 claims 1
- KSNPPAAJRVWQDR-UHFFFAOYSA-N 3-ethoxy-n-(2-fluoroethyl)-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]benzamide Chemical compound CCOC1=CC(C(=O)NCCF)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 KSNPPAAJRVWQDR-UHFFFAOYSA-N 0.000 claims 1
- VOKDMYZGCMSTTP-UHFFFAOYSA-N 3-ethoxy-n-ethyl-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-methylbenzamide Chemical compound CCOC1=CC(C(=O)N(C)CC)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 VOKDMYZGCMSTTP-UHFFFAOYSA-N 0.000 claims 1
- UQUPLLIMNXZNMA-UHFFFAOYSA-N 3-ethoxy-n-ethyl-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(2-methoxyethyl)benzamide Chemical compound CCOC1=CC(C(=O)N(CC)CCOC)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 UQUPLLIMNXZNMA-UHFFFAOYSA-N 0.000 claims 1
- FCRAKRSLWGXTEG-UHFFFAOYSA-N 4-[2-(2,4-dimethoxyanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-n-[(4-fluorophenyl)methyl]benzamide Chemical compound COC1=CC(OC)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 FCRAKRSLWGXTEG-UHFFFAOYSA-N 0.000 claims 1
- FACFFEMDZKGRRH-UHFFFAOYSA-N 4-[2-(2-cyclopropyloxy-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-n-[(4-fluorophenyl)methyl]benzamide Chemical compound C1CC1OC1=CC(S(=O)(=O)C)=CC=C1NC(=NN1C=2)N=C1C=CC=2C(C=C1)=CC=C1C(=O)NCC1=CC=C(F)C=C1 FACFFEMDZKGRRH-UHFFFAOYSA-N 0.000 claims 1
- SXMSMZWRXJKOOS-UHFFFAOYSA-N 4-[2-(2-ethoxy-4-ethylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-n-[(4-fluorophenyl)methyl]benzamide Chemical compound CCOC1=CC(S(=O)(=O)CC)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 SXMSMZWRXJKOOS-UHFFFAOYSA-N 0.000 claims 1
- XSMVZXBMVPCXCX-UHFFFAOYSA-N 4-[2-(2-ethoxy-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-n-[(4-fluorophenyl)methyl]benzamide Chemical compound CCOC1=CC(S(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 XSMVZXBMVPCXCX-UHFFFAOYSA-N 0.000 claims 1
- FYQMKIHMJWTVPK-UHFFFAOYSA-N 4-[2-(2-methoxy-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-n-[(4-methylphenyl)methyl]benzamide Chemical compound COC1=CC(S(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(C)=CC=3)C=CC2=N1 FYQMKIHMJWTVPK-UHFFFAOYSA-N 0.000 claims 1
- SGHKBULAOGAALR-UHFFFAOYSA-N 4-[2-(2-methyl-4-methylsulfinylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-n-[(4-methylphenyl)methyl]benzamide Chemical compound C1=CC(C)=CC=C1CNC(=O)C1=CC=C(C2=CN3N=C(NC=4C(=CC(=CC=4)S(C)=O)C)N=C3C=C2)C=C1 SGHKBULAOGAALR-UHFFFAOYSA-N 0.000 claims 1
- QZGQAOOKHGOLRY-UHFFFAOYSA-N 4-[2-(2-methyl-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-n-[(4-methylphenyl)methyl]benzamide Chemical compound C1=CC(C)=CC=C1CNC(=O)C1=CC=C(C2=CN3N=C(NC=4C(=CC(=CC=4)S(C)(=O)=O)C)N=C3C=C2)C=C1 QZGQAOOKHGOLRY-UHFFFAOYSA-N 0.000 claims 1
- FFDOWBGXAYABPG-UHFFFAOYSA-N 4-[2-[2-(difluoromethoxy)-4-ethylsulfonylanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-n-[(4-fluorophenyl)methyl]benzamide Chemical compound FC(F)OC1=CC(S(=O)(=O)CC)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 FFDOWBGXAYABPG-UHFFFAOYSA-N 0.000 claims 1
- FEXAIVLXHKVVOK-UHFFFAOYSA-N 4-[2-[2-(difluoromethoxy)-4-fluoroanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-n-[(4-fluorophenyl)methyl]benzamide Chemical compound FC(F)OC1=CC(F)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 FEXAIVLXHKVVOK-UHFFFAOYSA-N 0.000 claims 1
- ULSBWFYMDWCDCD-UHFFFAOYSA-N 4-[2-[2-(difluoromethoxy)-4-methylsulfonylanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-n-[(4-fluorophenyl)methyl]benzamide Chemical compound FC(F)OC1=CC(S(=O)(=O)C)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 ULSBWFYMDWCDCD-UHFFFAOYSA-N 0.000 claims 1
- OHNIQEVDRFTZID-UHFFFAOYSA-N 4-[2-[2-(difluoromethoxy)-4-propan-2-ylsulfonylanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-n-[(4-fluorophenyl)methyl]benzamide Chemical compound FC(F)OC1=CC(S(=O)(=O)C(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 OHNIQEVDRFTZID-UHFFFAOYSA-N 0.000 claims 1
- PYRNNZOSWWDTTL-UHFFFAOYSA-N 4-[2-[4-(dimethylamino)-2-methylanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-n-[(4-fluorophenyl)methyl]benzamide Chemical compound CC1=CC(N(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 PYRNNZOSWWDTTL-UHFFFAOYSA-N 0.000 claims 1
- MAVHHPHNHMYAAC-UHFFFAOYSA-N 4-[2-[4-(tert-butylsulfamoyl)-2-methoxyanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-n-[(4-fluorophenyl)methyl]benzamide Chemical compound COC1=CC(S(=O)(=O)NC(C)(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 MAVHHPHNHMYAAC-UHFFFAOYSA-N 0.000 claims 1
- CPZFOEWEADCORZ-UHFFFAOYSA-N 4-[[6-[4-(cyclopropylmethylcarbamoyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-ethoxy-n-(2-hydroxyethyl)benzamide Chemical compound CCOC1=CC(C(=O)NCCO)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC3CC3)C=CC2=N1 CPZFOEWEADCORZ-UHFFFAOYSA-N 0.000 claims 1
- XZNNBTBMKSLPRU-UHFFFAOYSA-N 4-[[6-[4-(cyclopropylmethylcarbamoyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-ethoxy-n-ethyl-n-(2-methoxyethyl)benzamide Chemical compound CCOC1=CC(C(=O)N(CC)CCOC)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC3CC3)C=CC2=N1 XZNNBTBMKSLPRU-UHFFFAOYSA-N 0.000 claims 1
- RZJHJAWCDKDRKJ-UHFFFAOYSA-N 4-[[6-[4-(cyclopropylmethylcarbamoyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(2-hydroxyethyl)-3-(2,2,2-trifluoroethoxy)benzamide Chemical compound FC(F)(F)COC1=CC(C(=O)NCCO)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC3CC3)C=CC2=N1 RZJHJAWCDKDRKJ-UHFFFAOYSA-N 0.000 claims 1
- FFJXCAOOXWGVBD-UHFFFAOYSA-N 4-[[6-[4-(cyclopropylmethylcarbamoyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-ethyl-3-(2,2,2-trifluoroethoxy)benzamide Chemical compound FC(F)(F)COC1=CC(C(=O)NCC)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC3CC3)C=CC2=N1 FFJXCAOOXWGVBD-UHFFFAOYSA-N 0.000 claims 1
- OPWZOAMUBDFJSI-UHFFFAOYSA-N 4-[[6-[4-[(2,4-difluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-(2,2,2-trifluoroethyl)benzamide Chemical compound COC1=CC(C(=O)NCC(F)(F)F)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C(=CC(F)=CC=3)F)C=CC2=N1 OPWZOAMUBDFJSI-UHFFFAOYSA-N 0.000 claims 1
- WPYLYISJYKEDGS-UHFFFAOYSA-N 4-[[6-[4-[(4-chlorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-(2,2,2-trifluoroethyl)benzamide Chemical compound COC1=CC(C(=O)NCC(F)(F)F)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(Cl)=CC=3)C=CC2=N1 WPYLYISJYKEDGS-UHFFFAOYSA-N 0.000 claims 1
- ZESPMBKRZCZQDK-UHFFFAOYSA-N 4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-(2,2,2-trifluoroethoxy)-n-(2,2,2-trifluoroethyl)benzamide Chemical compound C1=CC(F)=CC=C1CNC(=O)C1=CC=C(C2=CN3N=C(NC=4C(=CC(=CC=4)C(=O)NCC(F)(F)F)OCC(F)(F)F)N=C3C=C2)C=C1 ZESPMBKRZCZQDK-UHFFFAOYSA-N 0.000 claims 1
- RKHXDXIJRYGZDL-UHFFFAOYSA-N 4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-(trifluoromethoxy)benzamide Chemical compound FC(F)(F)OC1=CC(C(=O)N)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 RKHXDXIJRYGZDL-UHFFFAOYSA-N 0.000 claims 1
- WZUGEJQBZJJMJO-UHFFFAOYSA-N 4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n,n-dimethylbenzamide Chemical compound COC1=CC(C(=O)N(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 WZUGEJQBZJJMJO-UHFFFAOYSA-N 0.000 claims 1
- TZEPCROYJOCIJJ-UHFFFAOYSA-N 4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-(2,2,2-trifluoroethyl)benzamide Chemical compound COC1=CC(C(=O)NCC(F)(F)F)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 TZEPCROYJOCIJJ-UHFFFAOYSA-N 0.000 claims 1
- WDJNMSYHCITZCQ-UHFFFAOYSA-N 4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-(2-methoxyethyl)benzamide Chemical compound COC1=CC(C(=O)NCCOC)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 WDJNMSYHCITZCQ-UHFFFAOYSA-N 0.000 claims 1
- ICEUGPDIYXFPRT-UHFFFAOYSA-N 4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-(2-methylsulfonylethyl)benzamide Chemical compound COC1=CC(C(=O)NCCS(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 ICEUGPDIYXFPRT-UHFFFAOYSA-N 0.000 claims 1
- AVMVLXAJGUAQEJ-UHFFFAOYSA-N 4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-methyl-n-[2-(methylamino)ethyl]benzamide Chemical compound COC1=CC(C(=O)N(C)CCNC)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 AVMVLXAJGUAQEJ-UHFFFAOYSA-N 0.000 claims 1
- WAPGIGHNANPHAZ-UHFFFAOYSA-N 4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-methylbenzamide Chemical compound COC1=CC(C(=O)NC)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 WAPGIGHNANPHAZ-UHFFFAOYSA-N 0.000 claims 1
- ZENOFAVGGROELN-UHFFFAOYSA-N 4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 ZENOFAVGGROELN-UHFFFAOYSA-N 0.000 claims 1
- MCRFNLSJPAJLFY-UHFFFAOYSA-N 4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methyl-n-(2,2,2-trifluoroethyl)benzamide Chemical compound CC1=CC(C(=O)NCC(F)(F)F)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 MCRFNLSJPAJLFY-UHFFFAOYSA-N 0.000 claims 1
- HXJBGLHXJUGGNC-UHFFFAOYSA-N 4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methylbenzamide Chemical compound CC1=CC(C(N)=O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 HXJBGLHXJUGGNC-UHFFFAOYSA-N 0.000 claims 1
- KGFLSJJSLFSTBR-UHFFFAOYSA-N 4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(1-hydroxy-2-methylpropan-2-yl)-3-(2,2,2-trifluoroethoxy)benzamide Chemical compound FC(F)(F)COC1=CC(C(=O)NC(C)(CO)C)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 KGFLSJJSLFSTBR-UHFFFAOYSA-N 0.000 claims 1
- XCZSLCPKGYMBJK-UHFFFAOYSA-N 4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(1-hydroxy-2-methylpropan-2-yl)-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC(C)(C)CO)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 XCZSLCPKGYMBJK-UHFFFAOYSA-N 0.000 claims 1
- RMTIFIKNWIXLED-UHFFFAOYSA-N 4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(2-hydroxy-2-methylpropyl)-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCC(C)(C)O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 RMTIFIKNWIXLED-UHFFFAOYSA-N 0.000 claims 1
- LVGNFHNHONMPTH-UHFFFAOYSA-N 4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(2-hydroxyethyl)-3-(2,2,2-trifluoroethoxy)benzamide Chemical compound FC(F)(F)COC1=CC(C(=O)NCCO)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 LVGNFHNHONMPTH-UHFFFAOYSA-N 0.000 claims 1
- JNSJBZIBGNVCTC-UHFFFAOYSA-N 4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(3-fluoropropyl)-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCF)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 JNSJBZIBGNVCTC-UHFFFAOYSA-N 0.000 claims 1
- OWQVKCVJHXSLOK-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-(2,2,2-trifluoroethoxy)-n-(2,2,2-trifluoroethyl)benzamide Chemical compound C1=CC(F)=CC=C1CC(=O)NC1=CC=C(C2=CN3N=C(NC=4C(=CC(=CC=4)C(=O)NCC(F)(F)F)OCC(F)(F)F)N=C3C=C2)C=C1 OWQVKCVJHXSLOK-UHFFFAOYSA-N 0.000 claims 1
- RKTSDVIPUPCSPF-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n,n-dimethylbenzamide Chemical compound COC1=CC(C(=O)N(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 RKTSDVIPUPCSPF-UHFFFAOYSA-N 0.000 claims 1
- XZOIVXCALVGJNH-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-(2,2,2-trifluoroethyl)benzamide Chemical compound COC1=CC(C(=O)NCC(F)(F)F)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 XZOIVXCALVGJNH-UHFFFAOYSA-N 0.000 claims 1
- DADWMMATHKGJIP-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-(2-methoxyethyl)benzamide Chemical compound COC1=CC(C(=O)NCCOC)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 DADWMMATHKGJIP-UHFFFAOYSA-N 0.000 claims 1
- NIGBOUJVBLXXPE-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-(2-methylsulfonylethyl)benzamide Chemical compound COC1=CC(C(=O)NCCS(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 NIGBOUJVBLXXPE-UHFFFAOYSA-N 0.000 claims 1
- XATXPKBOQADWMH-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-methyl-n-(2,2,2-trifluoroethyl)benzamide Chemical compound COC1=CC(C(=O)N(C)CC(F)(F)F)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 XATXPKBOQADWMH-UHFFFAOYSA-N 0.000 claims 1
- RVJGGRNFFCJSEJ-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-methyl-n-[2-(methylamino)ethyl]benzamide Chemical compound COC1=CC(C(=O)N(C)CCNC)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 RVJGGRNFFCJSEJ-UHFFFAOYSA-N 0.000 claims 1
- HMUGPPNQUFSYBS-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-methylbenzamide Chemical compound COC1=CC(C(=O)NC)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 HMUGPPNQUFSYBS-UHFFFAOYSA-N 0.000 claims 1
- RAWZIQRCKUPYPE-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 RAWZIQRCKUPYPE-UHFFFAOYSA-N 0.000 claims 1
- YMOYMCYREOGBBJ-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methyl-n-(2,2,2-trifluoroethyl)benzamide Chemical compound CC1=CC(C(=O)NCC(F)(F)F)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 YMOYMCYREOGBBJ-UHFFFAOYSA-N 0.000 claims 1
- LWWKPQWDEDXMPV-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methylbenzamide Chemical compound CC1=CC(C(N)=O)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 LWWKPQWDEDXMPV-UHFFFAOYSA-N 0.000 claims 1
- YHWOPEAYOKDTJG-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n,n,3-trimethylbenzamide Chemical compound CC1=CC(C(=O)N(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 YHWOPEAYOKDTJG-UHFFFAOYSA-N 0.000 claims 1
- MEJBPOHVYYYUPR-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(1-hydroxy-2-methylpropan-2-yl)-3-(2,2,2-trifluoroethoxy)benzamide Chemical compound FC(F)(F)COC1=CC(C(=O)NC(C)(CO)C)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 MEJBPOHVYYYUPR-UHFFFAOYSA-N 0.000 claims 1
- OGWRAFNNMGCIMI-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(1-hydroxy-2-methylpropan-2-yl)-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC(C)(C)CO)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 OGWRAFNNMGCIMI-UHFFFAOYSA-N 0.000 claims 1
- DTSMPXAIXZBRHF-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(2-hydroxy-2-methylpropyl)-3-(2,2,2-trifluoroethoxy)benzamide Chemical compound FC(F)(F)COC1=CC(C(=O)NCC(C)(O)C)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 DTSMPXAIXZBRHF-UHFFFAOYSA-N 0.000 claims 1
- DANWDACOBONHBO-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(2-hydroxy-2-methylpropyl)-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCC(C)(C)O)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 DANWDACOBONHBO-UHFFFAOYSA-N 0.000 claims 1
- ZTGCPNWSUQPBHN-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(2-hydroxyethyl)-3-(2,2,2-trifluoroethoxy)benzamide Chemical compound FC(F)(F)COC1=CC(C(=O)NCCO)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 ZTGCPNWSUQPBHN-UHFFFAOYSA-N 0.000 claims 1
- QDEBDTKUOGBJOL-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(2-hydroxyethyl)-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCO)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 QDEBDTKUOGBJOL-UHFFFAOYSA-N 0.000 claims 1
- LLKAPLHVCMNZIH-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(2-methylsulfonylethyl)-3-(2,2,2-trifluoroethoxy)benzamide Chemical compound FC(F)(F)COC1=CC(C(=O)NCCS(=O)(=O)C)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 LLKAPLHVCMNZIH-UHFFFAOYSA-N 0.000 claims 1
- WCSRPFZWEISFSM-UHFFFAOYSA-N 4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-n-(3-fluoropropyl)-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCCF)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 WCSRPFZWEISFSM-UHFFFAOYSA-N 0.000 claims 1
- 102100022681 40S ribosomal protein S27 Human genes 0.000 claims 1
- WKJIOJHRARDFEY-UHFFFAOYSA-N 5-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-4-methyl-n-(2,2,2-trifluoroethyl)pyridine-2-carboxamide Chemical compound CC1=CC(C(=O)NCC(F)(F)F)=NC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 WKJIOJHRARDFEY-UHFFFAOYSA-N 0.000 claims 1
- WYWHKKSPHMUBEB-UHFFFAOYSA-N 6-Mercaptoguanine Natural products N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 claims 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 claims 1
- 108010006654 Bleomycin Proteins 0.000 claims 1
- GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 claims 1
- GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 claims 1
- PTOAARAWEBMLNO-KVQBGUIXSA-N Cladribine Chemical compound C1=NC=2C(N)=NC(Cl)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 PTOAARAWEBMLNO-KVQBGUIXSA-N 0.000 claims 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 claims 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims 1
- 101000678466 Homo sapiens 40S ribosomal protein S27 Proteins 0.000 claims 1
- XDXDZDZNSLXDNA-TZNDIEGXSA-N Idarubicin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XDXDZDZNSLXDNA-TZNDIEGXSA-N 0.000 claims 1
- XDXDZDZNSLXDNA-UHFFFAOYSA-N Idarubicin Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XDXDZDZNSLXDNA-UHFFFAOYSA-N 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims 1
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims 1
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 claims 1
- 229940123237 Taxane Drugs 0.000 claims 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 claims 1
- 229940009456 adriamycin Drugs 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 230000002280 anti-androgenic effect Effects 0.000 claims 1
- 239000000051 antiandrogen Substances 0.000 claims 1
- 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 claims 1
- 150000001502 aryl halides Chemical class 0.000 claims 1
- VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 claims 1
- 229960000997 bicalutamide Drugs 0.000 claims 1
- 229960001561 bleomycin Drugs 0.000 claims 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 claims 1
- GXJABQQUPOEUTA-RDJZCZTQSA-N bortezomib Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)B(O)O)NC(=O)C=1N=CC=NC=1)C1=CC=CC=C1 GXJABQQUPOEUTA-RDJZCZTQSA-N 0.000 claims 1
- 229960001467 bortezomib Drugs 0.000 claims 1
- 229960004117 capecitabine Drugs 0.000 claims 1
- 229960004562 carboplatin Drugs 0.000 claims 1
- 229940047583 cetamide Drugs 0.000 claims 1
- 229960004630 chlorambucil Drugs 0.000 claims 1
- JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 claims 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims 1
- 229960004316 cisplatin Drugs 0.000 claims 1
- 229960004397 cyclophosphamide Drugs 0.000 claims 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 229960000978 cyproterone acetate Drugs 0.000 claims 1
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 claims 1
- 229960000684 cytarabine Drugs 0.000 claims 1
- 229960000975 daunorubicin Drugs 0.000 claims 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 claims 1
- 229960003957 dexamethasone Drugs 0.000 claims 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 229960003668 docetaxel Drugs 0.000 claims 1
- 229960004679 doxorubicin Drugs 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- FRPJXPJMRWBBIH-RBRWEJTLSA-N estramustine Chemical compound ClCCN(CCCl)C(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 FRPJXPJMRWBBIH-RBRWEJTLSA-N 0.000 claims 1
- 229960001842 estramustine Drugs 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 claims 1
- 229960005420 etoposide Drugs 0.000 claims 1
- 229960000390 fludarabine Drugs 0.000 claims 1
- GIUYCYHIANZCFB-FJFJXFQQSA-N fludarabine phosphate Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O GIUYCYHIANZCFB-FJFJXFQQSA-N 0.000 claims 1
- 229960002949 fluorouracil Drugs 0.000 claims 1
- 229960002074 flutamide Drugs 0.000 claims 1
- MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 201000005787 hematologic cancer Diseases 0.000 claims 1
- 208000019691 hematopoietic and lymphoid cell neoplasm Diseases 0.000 claims 1
- 229960000908 idarubicin Drugs 0.000 claims 1
- 229960001101 ifosfamide Drugs 0.000 claims 1
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 229960001924 melphalan Drugs 0.000 claims 1
- SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 claims 1
- 229960000485 methotrexate Drugs 0.000 claims 1
- 229960001156 mitoxantrone Drugs 0.000 claims 1
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 claims 1
- YLULPNWRGSMGMX-UHFFFAOYSA-N n,n-diethyl-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-(2,2,2-trifluoroethoxy)benzamide Chemical compound FC(F)(F)COC1=CC(C(=O)N(CC)CC)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 YLULPNWRGSMGMX-UHFFFAOYSA-N 0.000 claims 1
- NNBCIPJVCURQSG-UHFFFAOYSA-N n,n-diethyl-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)N(CC)CC)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 NNBCIPJVCURQSG-UHFFFAOYSA-N 0.000 claims 1
- OGZWDYBCANGCKI-UHFFFAOYSA-N n,n-diethyl-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-propan-2-yloxybenzamide Chemical compound CC(C)OC1=CC(C(=O)N(CC)CC)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 OGZWDYBCANGCKI-UHFFFAOYSA-N 0.000 claims 1
- KDUJDDIIABWPJU-UHFFFAOYSA-N n,n-diethyl-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-propoxybenzamide Chemical compound CCCOC1=CC(C(=O)N(CC)CC)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 KDUJDDIIABWPJU-UHFFFAOYSA-N 0.000 claims 1
- KIHBTNUJCUUJLO-UHFFFAOYSA-N n-(2,2-difluoroethyl)-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCC(F)F)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 KIHBTNUJCUUJLO-UHFFFAOYSA-N 0.000 claims 1
- JEPKRGPITPUMJF-UHFFFAOYSA-N n-(2,2-difluoroethyl)-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCC(F)F)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 JEPKRGPITPUMJF-UHFFFAOYSA-N 0.000 claims 1
- AIZQPQWHUCVGAO-UHFFFAOYSA-N n-(2-ethoxyethyl)-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCOCC)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 AIZQPQWHUCVGAO-UHFFFAOYSA-N 0.000 claims 1
- XYNMSLAWOZGFKD-UHFFFAOYSA-N n-(2-ethoxyethyl)-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCOCC)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 XYNMSLAWOZGFKD-UHFFFAOYSA-N 0.000 claims 1
- XLAKONHZQDCIEH-UHFFFAOYSA-N n-(2-fluoroethyl)-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-(2,2,2-trifluoroethoxy)benzamide Chemical compound FC(F)(F)COC1=CC(C(=O)NCCF)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 XLAKONHZQDCIEH-UHFFFAOYSA-N 0.000 claims 1
- MYNJEMQLRIOLHH-UHFFFAOYSA-N n-(2-fluoroethyl)-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCF)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 MYNJEMQLRIOLHH-UHFFFAOYSA-N 0.000 claims 1
- MZLBVRVSJDKQOR-UHFFFAOYSA-N n-(2-fluoroethyl)-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methylbenzamide Chemical compound CC1=CC(C(=O)NCCF)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 MZLBVRVSJDKQOR-UHFFFAOYSA-N 0.000 claims 1
- YKJAIDYAGJECHO-UHFFFAOYSA-N n-(2-fluoroethyl)-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCF)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 YKJAIDYAGJECHO-UHFFFAOYSA-N 0.000 claims 1
- FVDPBKRJJVCMPT-UHFFFAOYSA-N n-[(2,4-difluorophenyl)methyl]-2-methyl-4-[2-[4-methylsulfonyl-2-(2,2,2-trifluoroethoxy)anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]benzamide Chemical compound CC1=CC(C2=CN3N=C(NC=4C(=CC(=CC=4)S(C)(=O)=O)OCC(F)(F)F)N=C3C=C2)=CC=C1C(=O)NCC1=CC=C(F)C=C1F FVDPBKRJJVCMPT-UHFFFAOYSA-N 0.000 claims 1
- HJEMLGQBMCZWPN-UHFFFAOYSA-N n-[(2,4-difluorophenyl)methyl]-4-[2-(2-methoxy-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]benzamide Chemical compound COC1=CC(S(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C(=CC(F)=CC=3)F)C=CC2=N1 HJEMLGQBMCZWPN-UHFFFAOYSA-N 0.000 claims 1
- BXMYWBQCQQRBCN-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-4-[2-(2-methoxy-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]benzamide Chemical compound COC1=CC(S(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(Cl)=CC=3)C=CC2=N1 BXMYWBQCQQRBCN-UHFFFAOYSA-N 0.000 claims 1
- RFMMWHAPUSEMBU-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-4-[2-(2-methyl-4-methylsulfinylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]benzamide Chemical compound CC1=CC(S(C)=O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(Cl)=CC=3)C=CC2=N1 RFMMWHAPUSEMBU-UHFFFAOYSA-N 0.000 claims 1
- UIVWTELBGUVCIC-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-4-[2-(2-methyl-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]benzamide Chemical compound CC1=CC(S(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(Cl)=CC=3)C=CC2=N1 UIVWTELBGUVCIC-UHFFFAOYSA-N 0.000 claims 1
- FCLQGYJCCHLWMU-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-2-methyl-4-[2-[4-methylsulfonyl-2-(2,2,2-trifluoroethoxy)anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]benzamide Chemical compound CC1=CC(C2=CN3N=C(NC=4C(=CC(=CC=4)S(C)(=O)=O)OCC(F)(F)F)N=C3C=C2)=CC=C1C(=O)NCC1=CC=C(F)C=C1 FCLQGYJCCHLWMU-UHFFFAOYSA-N 0.000 claims 1
- CQTGEPJSLSHSFP-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-4-[2-(2-methoxy-4-methylsulfinylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]benzamide Chemical compound COC1=CC(S(C)=O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 CQTGEPJSLSHSFP-UHFFFAOYSA-N 0.000 claims 1
- KJTGLXIKIHJFGM-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-4-[2-(2-methoxy-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]benzamide Chemical compound COC1=CC(S(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 KJTGLXIKIHJFGM-UHFFFAOYSA-N 0.000 claims 1
- UMZHZTSUZXJEOS-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-4-[2-(2-methyl-4-methylsulfinylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]benzamide Chemical compound CC1=CC(S(C)=O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 UMZHZTSUZXJEOS-UHFFFAOYSA-N 0.000 claims 1
- JNTUZSGLCKIQEF-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-4-[2-(2-methyl-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]benzamide Chemical compound CC1=CC(S(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 JNTUZSGLCKIQEF-UHFFFAOYSA-N 0.000 claims 1
- FHNHNJDMNZWMLT-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-4-[2-(4-methoxy-2-methylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]benzamide Chemical compound CC1=CC(OC)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 FHNHNJDMNZWMLT-UHFFFAOYSA-N 0.000 claims 1
- KDYHIHMVASSRMF-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-4-[2-[2-methoxy-4-(methylsulfonimidoyl)anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]benzamide Chemical compound COC1=CC(S(C)(=N)=O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 KDYHIHMVASSRMF-UHFFFAOYSA-N 0.000 claims 1
- QRANVNZPCCAWPS-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-4-[2-[4-(2-hydroxypropan-2-yl)-2-methoxyanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-2-methoxybenzamide Chemical compound COC1=CC(C(C)(C)O)=CC=C1NC1=NN2C=C(C=3C=C(OC)C(C(=O)NCC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 QRANVNZPCCAWPS-UHFFFAOYSA-N 0.000 claims 1
- QELNXODTLCWXDZ-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-4-[2-[4-(2-hydroxypropan-2-yl)-2-methoxyanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]benzamide Chemical compound COC1=CC(C(C)(C)O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 QELNXODTLCWXDZ-UHFFFAOYSA-N 0.000 claims 1
- CRTOFESISWFZAU-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-4-[2-[4-(hydroxymethyl)-2-methoxyanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]benzamide Chemical compound COC1=CC(CO)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 CRTOFESISWFZAU-UHFFFAOYSA-N 0.000 claims 1
- CEBVLJRJJQYVKV-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-4-[2-[4-(methanesulfonamido)-2-methylanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]benzamide Chemical compound CC1=CC(NS(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 CEBVLJRJJQYVKV-UHFFFAOYSA-N 0.000 claims 1
- VJETYSMJYQPBFE-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-4-[2-[4-[(1-hydroxy-2-methylpropan-2-yl)carbamoyl]-2-methoxyanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-2-methoxybenzamide Chemical compound COC1=CC(C(=O)NC(C)(C)CO)=CC=C1NC1=NN2C=C(C=3C=C(OC)C(C(=O)NCC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 VJETYSMJYQPBFE-UHFFFAOYSA-N 0.000 claims 1
- GMDHUBVLTKDEBE-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-4-[2-[4-[(1-hydroxy-2-methylpropan-2-yl)carbamoyl]-2-methoxyanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-2-methylbenzamide Chemical compound COC1=CC(C(=O)NC(C)(C)CO)=CC=C1NC1=NN2C=C(C=3C=C(C)C(C(=O)NCC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 GMDHUBVLTKDEBE-UHFFFAOYSA-N 0.000 claims 1
- MMBNWTKRVCOPSO-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-4-[2-[4-methylsulfonyl-2-(2,2,2-trifluoroethoxy)anilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]benzamide Chemical compound FC(F)(F)COC1=CC(S(=O)(=O)C)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 MMBNWTKRVCOPSO-UHFFFAOYSA-N 0.000 claims 1
- YJDVGJVWGSIAOH-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-3-ethoxy-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]benzamide Chemical compound CCOC1=CC(C(=O)NCCN(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 YJDVGJVWGSIAOH-UHFFFAOYSA-N 0.000 claims 1
- MBMLMBCNVLDBKI-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-3-ethoxy-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]benzamide Chemical compound CCOC1=CC(C(=O)NCCN(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 MBMLMBCNVLDBKI-UHFFFAOYSA-N 0.000 claims 1
- XBMGEVCRGQDPON-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-(2,2,2-trifluoroethoxy)benzamide Chemical compound FC(F)(F)COC1=CC(C(=O)NCCN(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 XBMGEVCRGQDPON-UHFFFAOYSA-N 0.000 claims 1
- ORJDPZNYQOVDER-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-methylbenzamide Chemical compound COC1=CC(C(=O)N(C)CCN(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 ORJDPZNYQOVDER-UHFFFAOYSA-N 0.000 claims 1
- SEHBRIWXBNROGU-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCN(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 SEHBRIWXBNROGU-UHFFFAOYSA-N 0.000 claims 1
- HLUAPQCZLMUDCJ-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-(2,2,2-trifluoroethoxy)benzamide Chemical compound FC(F)(F)COC1=CC(C(=O)NCCN(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 HLUAPQCZLMUDCJ-UHFFFAOYSA-N 0.000 claims 1
- HHODUNDEOHNIRF-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-methylbenzamide Chemical compound COC1=CC(C(=O)N(C)CCN(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 HHODUNDEOHNIRF-UHFFFAOYSA-N 0.000 claims 1
- WDYRZLPJCWHHJM-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCCN(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 WDYRZLPJCWHHJM-UHFFFAOYSA-N 0.000 claims 1
- HBGKZLVIXUCYNX-UHFFFAOYSA-N n-[2-[acetyl(methyl)amino]ethyl]-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-methylbenzamide Chemical compound COC1=CC(C(=O)N(C)CCN(C)C(C)=O)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 HBGKZLVIXUCYNX-UHFFFAOYSA-N 0.000 claims 1
- IDLKRRWMQMXVHB-UHFFFAOYSA-N n-[2-[acetyl(methyl)amino]ethyl]-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-methylbenzamide Chemical compound COC1=CC(C(=O)N(C)CCN(C)C(C)=O)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 IDLKRRWMQMXVHB-UHFFFAOYSA-N 0.000 claims 1
- NGCUQWWOQRRSCV-UHFFFAOYSA-N n-[4-[2-(2,4-dimethoxyanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-2-(4-fluorophenyl)acetamide Chemical compound COC1=CC(OC)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 NGCUQWWOQRRSCV-UHFFFAOYSA-N 0.000 claims 1
- IRRKPAIWEFXFCP-UHFFFAOYSA-N n-[4-[2-(2-cyclopropyloxy-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-2-(4-fluorophenyl)acetamide Chemical compound C1CC1OC1=CC(S(=O)(=O)C)=CC=C1NC(=NN1C=2)N=C1C=CC=2C(C=C1)=CC=C1NC(=O)CC1=CC=C(F)C=C1 IRRKPAIWEFXFCP-UHFFFAOYSA-N 0.000 claims 1
- MXERVWHMHIBKDN-UHFFFAOYSA-N n-[4-[2-(2-ethoxy-4-ethylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-2-(4-fluorophenyl)acetamide Chemical compound CCOC1=CC(S(=O)(=O)CC)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 MXERVWHMHIBKDN-UHFFFAOYSA-N 0.000 claims 1
- HJSXMBIWAUULQQ-UHFFFAOYSA-N n-[4-[2-(2-ethoxy-4-fluoroanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-2-(4-fluorophenyl)acetamide Chemical compound CCOC1=CC(F)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 HJSXMBIWAUULQQ-UHFFFAOYSA-N 0.000 claims 1
- GIDHZYNNBHIGTK-UHFFFAOYSA-N n-[4-[2-(2-ethoxy-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-2-(4-fluorophenyl)acetamide Chemical compound CCOC1=CC(S(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 GIDHZYNNBHIGTK-UHFFFAOYSA-N 0.000 claims 1
- FGOHVMPBOQLZGX-UHFFFAOYSA-N n-[4-[2-(2-methoxy-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-2-phenylacetamide Chemical compound COC1=CC(S(C)(=O)=O)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC=CC=4)=CC=3)C=CC2=N1 FGOHVMPBOQLZGX-UHFFFAOYSA-N 0.000 claims 1
- DMAJORPFXLBYCW-UHFFFAOYSA-N n-[4-[2-(4-cyano-2-methoxyanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-2-(4-fluorophenyl)acetamide Chemical compound COC1=CC(C#N)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 DMAJORPFXLBYCW-UHFFFAOYSA-N 0.000 claims 1
- NPJBPWYVECSYBL-UHFFFAOYSA-N n-[4-[2-(5-fluoro-2-methoxy-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-2-(4-fluorophenyl)acetamide Chemical compound COC1=CC(S(C)(=O)=O)=C(F)C=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 NPJBPWYVECSYBL-UHFFFAOYSA-N 0.000 claims 1
- MSAMIWJHZCFKCT-UHFFFAOYSA-N n-[4-[2-[2-(difluoromethoxy)-4-fluoroanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-2-(4-fluorophenyl)acetamide Chemical compound FC(F)OC1=CC(F)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 MSAMIWJHZCFKCT-UHFFFAOYSA-N 0.000 claims 1
- ZEOOTLDHABZVPN-UHFFFAOYSA-N n-[4-[2-[2-(difluoromethoxy)-4-methylsulfonylanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-2-(4-fluorophenyl)acetamide Chemical compound FC(F)OC1=CC(S(=O)(=O)C)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 ZEOOTLDHABZVPN-UHFFFAOYSA-N 0.000 claims 1
- ARECGPGFOKYZFN-UHFFFAOYSA-N n-[4-[2-[2-(difluoromethoxy)-4-propan-2-ylsulfonylanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-2-(4-fluorophenyl)acetamide Chemical compound FC(F)OC1=CC(S(=O)(=O)C(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 ARECGPGFOKYZFN-UHFFFAOYSA-N 0.000 claims 1
- KBQVSCLYDSQOPV-UHFFFAOYSA-N n-[4-[2-[4-(dimethylamino)-2-methylanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-2-(4-fluorophenyl)acetamide Chemical compound CC1=CC(N(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 KBQVSCLYDSQOPV-UHFFFAOYSA-N 0.000 claims 1
- SIUFLHBCMVOWJV-UHFFFAOYSA-N n-[4-[2-[4-(tert-butylsulfamoyl)-2-methoxyanilino]-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]-2-(4-fluorophenyl)acetamide Chemical compound COC1=CC(S(=O)(=O)NC(C)(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 SIUFLHBCMVOWJV-UHFFFAOYSA-N 0.000 claims 1
- NDSMYLTUQAZUAG-UHFFFAOYSA-N n-ethyl-4-[[6-[4-[(3-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCC)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=C(F)C=CC=3)C=CC2=N1 NDSMYLTUQAZUAG-UHFFFAOYSA-N 0.000 claims 1
- RUZMXDZMCXRBMT-UHFFFAOYSA-N n-ethyl-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NCC)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 RUZMXDZMCXRBMT-UHFFFAOYSA-N 0.000 claims 1
- UEQCPQKKGCGHOJ-UHFFFAOYSA-N n-ethyl-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methylbenzamide Chemical compound CC1=CC(C(=O)NCC)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 UEQCPQKKGCGHOJ-UHFFFAOYSA-N 0.000 claims 1
- YSLZWBMXMOCFMB-UHFFFAOYSA-N n-ethyl-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxy-n-methylbenzamide Chemical compound COC1=CC(C(=O)N(C)CC)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 YSLZWBMXMOCFMB-UHFFFAOYSA-N 0.000 claims 1
- DPCIMJVCFOGFDA-UHFFFAOYSA-N n-ethyl-5-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-4-methylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)NCC)=CC(C)=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 DPCIMJVCFOGFDA-UHFFFAOYSA-N 0.000 claims 1
- ZPGGHLJLJJRKFL-UHFFFAOYSA-N n-tert-butyl-3-ethoxy-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]benzamide Chemical compound CCOC1=CC(C(=O)NC(C)(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 ZPGGHLJLJJRKFL-UHFFFAOYSA-N 0.000 claims 1
- USKWCSNLPKEOJK-UHFFFAOYSA-N n-tert-butyl-4-[[6-[4-[(4-fluorophenyl)methylcarbamoyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC(C)(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(=CC=3)C(=O)NCC=3C=CC(F)=CC=3)C=CC2=N1 USKWCSNLPKEOJK-UHFFFAOYSA-N 0.000 claims 1
- RYMDBAHJXXKSEK-UHFFFAOYSA-N n-tert-butyl-4-[[6-[4-[[2-(4-fluorophenyl)acetyl]amino]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-methoxybenzamide Chemical compound COC1=CC(C(=O)NC(C)(C)C)=CC=C1NC1=NN2C=C(C=3C=CC(NC(=O)CC=4C=CC(F)=CC=4)=CC=3)C=CC2=N1 RYMDBAHJXXKSEK-UHFFFAOYSA-N 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 150000003057 platinum Chemical class 0.000 claims 1
- 229960005205 prednisolone Drugs 0.000 claims 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 claims 1
- CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 claims 1
- 229960000624 procarbazine Drugs 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 229960004641 rituximab Drugs 0.000 claims 1
- MNRILEROXIRVNJ-UHFFFAOYSA-N tioguanine Chemical compound N1C(N)=NC(=S)C2=NC=N[C]21 MNRILEROXIRVNJ-UHFFFAOYSA-N 0.000 claims 1
- 229960003087 tioguanine Drugs 0.000 claims 1
- WTVXIBRMWGUIMI-UHFFFAOYSA-N trifluoro($l^{1}-oxidanylsulfonyl)methane Chemical group [O]S(=O)(=O)C(F)(F)F WTVXIBRMWGUIMI-UHFFFAOYSA-N 0.000 claims 1
- 229960003048 vinblastine Drugs 0.000 claims 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 claims 1
- 229960004528 vincristine Drugs 0.000 claims 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 claims 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Claims (16)
1. Spoj opće formule (I) :
[image]
naznačen time da :
R1 predstavlja fenil ili piridil skupinu
- koja je supstituirana, jednom ili više puta, identično ili različito, sa supstituentom odabranim od:
R6-(C1-C6-alkoksi)-, R6-O-, -C(=O)R6, -C(=O)O-R6, -N(H)C(=O)R6, -N(H)C(=O)NR6R7, -NR6R7, -C(=O)N(H)R6, -C(=O)NR6R7, R6-S-, R6-S(=O)2-, -N(H)S(=O)2R6, -S(=O)2N(H)R6; i
- koja je proizvoljno supstituirana, jednom ili više puta, identično ili različito, sa supstituentom odabranim od:
halo-, hidroksi-, nitro-, C1-C6-alkil-, C1-C6-alkoksi-, hidroksi-C1-C6-alkil-, -N(H)C(=O)R8, -N(H)C(=O)NR8R7, -C(=O)N(H)R8, -N(H)S(=O)2R8;
R2 predstavlja
[image]
pri čemu * označava točku vezanja navedene skupine s ostatkom molekule;
Q1 predstavlja skupinu odabranu od: N, CH, C-(C1-C6-alkil), C-(C1-C6-alkoksi), C-halo;
Q2 predstavlja skupinu odabranu od: N, CH, CR5b;
Q3 predstavlja skupinu odabranu od: N, CH, CR5b;
R5a predstavlja skupinu odabranu od:
halo-, nitro-, C1-C6-alkil-, halo-C1-C6-alkil-, C1-C6-alkoksi-, halo-C1-C6-alkoksi-, hidroksi-C1-C6-alkil-, C1-C6-alkoksi-C1-C6-alkil-, halo-C1-C6-alkoksi-C1-C6-alkil-, R8-(C1-C6-alkoksi)-, R8-O-, -NR8R7, R8-S-, R8-S(=O)-, R8-S(=O)2-, (C3-C6-cikloalkil)-(CH2)n-O-;
R5b predstavlja skupinu odabranu od:
halo-, hidroksi-, cijano-, nitro-, C1-C6-alkil-, halo-C1-C6-alkil-, C1-C6-alkoksi-, halo-C1-C6-alkoksi-, hidroksi-C1-C6-alkil-, C1-C6-alkoksi-C1-C6-alkil-, halo-C1-C6-alkoksi-C1-C6-alkil-, R8-(C1-C6-alkil)-, R8-(CH2)n(CHOH)(CH2)m-, R8-(C1-C6-alkoksi)-, R8-(CH2)n(CHOH)(CH2)p-O-, R8-(C1-C6-alkoksi-C1-C6-alkil)-, R8-(C1-C6-alkoksi-C1-C6-alkil)-O-, -O-(CH2)n-C(=O)NR8R7, R8-O-, -C(=O)R8, -C(=O)O-R8, -OC(=O)-R8, -N(H)C(=O)R8, -N(R7)C(=O)R8, -N(H)C(=O)NR8R7, -N(R7)C(=O)NR8R7, -NR8R7, -NR7R7, -C(=O)N(H)R8, -C(0=ONR8R7, R8-S-, R8-S(=O)-, R8-S(=O)2-, -N(H)S(=O)R8, -N(R7)S(=O)R8, -S(=O)N(H)R8, -S(=O)NR8R7, -N(H)S(=O)2R8, -N(R7)S(=O)2R8, -S(=O)2N(H)R8, -S(=O)2NR8R7, -S(=O)(=NR8)R7, -S(=O)(=NR7)R8, -N=S(=O)(R8)R7;
R3 predstavlja atom vodika, atom halogena, hidroksi-, amino-, cijano-, nitro-, C1-C4-alkil-, halo-C1-C4-alkil-, C1-C4-alkoksi-, halo-C1-C4-alkoksi-, hidroksi-C1-C4-alkil-, C1-C4-alkoksi-C1-C4-alkil-, halo-C1-C4-alkoksi-C1-C4-alkil-, C2-C6-alkenil-, C2-C6-alkinil-, halo-C2-C6-alkenil-, halo-C2-C6-alkinil-, C3-C6-cikloalkil-, ili halo-C3-C6-cikloalkil- skupinu;
R4 predstavlja atom vodika, atom halogena, hidroksi-, amino-, cijano-, nitro-, C1-C4-alkil-, halo-C1-C4-alkil-, C1-C4-alkoksi-, halo-C1-C4-alkoksi-, hidroksi-C1-C4-alkil-, C1-C4-alkoksi-C1-C4-alkil-, halo-C1-C4-alkoksi-C1-C4-alkil-, C2-C6-alkenil-, C2-C6-alkinil-, halo-C2-C6-alkenil-, halo-C2-C6-alkinil-, C3-C6-cikloalkil-, ili halo-C3-C6-cikloalkil- skupinu;
R5 predstavlja atom vodika;
R6 predstavlja skupinu odabranu od C3-C6-cikloalkila-, 3- do 10-članog heterociklila-, arila-, heteroarila-, -(CH2)q-(C3-C6-cikloalkil), -(CH2)q-(3- do 10-članog heterociklila), -(CH2)q-arila, ili -(CH2)q-heteroarila,
pri čemu je navedena skupina proizvoljno supstituirana, jednom ili više puta, identično ili različito, sa supstituentom odabranim od: halo-, hidroksi-, cijano-, nitro-, C1-C6-alkil-, halo-C1-C6-alkil-, C1-C6-alkoksi-, halo-C1-C6-alkoksi-, hidroksi-C1-C6-alkil-, C1-C6-alkoksi-C1-C6-alkil-, halo-C1-C6-alkoksi-C1-C6-alkil-, R8-(C1-C6-alkil)-, R8-(CH2)n(CHOH)(CH2)m-, R8-(C1-C6-alkoksi)-, R8-(CH2)n(CHOH)(CH2)p-O-, R8-(C1-C6-alkoksi-C1-C6-alkil)-, R8-(C1-C6-alkoksi-C1-C6-alkil)-O-, aril-, R8-O-, -C(=O)R8, -C(=O)O-R8, -OC(=O)-R8, -N(H)C(=O)R8, -N(R7)C(=O)R8, -N(H)C(=O)NR8R7, -N(R7)C(=O)NR8R7, -NR8R7, -C(=O)N(H)R8, -C(=O)NR8R7, R8-S-, R8-S(=O)-, R8-S(=O)2-, -N(H)S(=O)R8, -N(R7)S(=O)R8, -S(=O)N(H)R8, -S(=O)NR8R7, -N(H)S(=O)2R8, -N(R7)S(=O)2R8, -S(=O)2N(H)R8, -S(=O)2NR8R7, -S(=O)(=NR8)R7,- S(=O)(=NR7)R8, -N=S(=O)(R8)R7;
R7 predstavlja atom vodika, C1-C6-alkil- ili C3-C6-cikloalkil- skupinu;
R8 predstavlja atom vodika ili C1-C6-alkil- ili C3-C6-cikloalkil- skupinu, pri čemu je navedena C1-C6-alkil- ili C3-C6-cikloalkil- skupina proizvoljno supstituirana, jednom ili više puta, identično ili različito, sa supstituentom odabranim od:
halo-, hidroksi-, -NHR7, -NR7R7, -N(C1-C3-alkil)-C(=O)R7,
-N(C1-C3-alkil)-C(=O)OR7, C1-C3-alkil-, R7-S(=O)2-, C1-C3-alkoksi-, halo-C1-C3-alkoksi-;
n, m, p, predstavljaju, međusobno neovisno, cijeli broj 0, 1, 2 ili 3;
i
q predstavlja cijeli broj 0, 1, 2 ili 3;
ili njegov stereoizomer, tautomer, N-oksid, hidrat, solvat, ili njegova sol, ili smjesa istih.
2. Spoj prema zahtjevu 1, naznačen time da:
R1 predstavlja fenil skupinu
- koja je supstituirana, jednom ili više puta, identično ili različito, sa supstituentom odabranim od:
R6-(C1-C6-alkoksi)-, R6-O-, -N(H)C(=O)R6, -N(H)C(=O)NR7, -C(=O)N(H)R6, -C(=O)NR6R7; te
- koja je proizvoljno supstituirana, jednom ili više puta, identično ili različito, sa supstituentom odabranim od:
halo-, C1-C6-alkil-, C1-C6-alkoksi-, -N(H)C(=O)R8, -C(=O)N(H)R8;
R3 predstavlja atom vodika, halo-, hidroksi-, C1-C4-alkil-, halo-C1-C4-alkil-, ili C1-C4-alkoksi- skupinu;
R4 predstavlja atom vodika, halo-, C1-C6-alkil-, halo-C1-C6-alkil- ili C1-C6-alkoksi- skupinu;
R5a predstavlja skupinu odabranu od:
halo-, C1-C6-alkil-,C1-C6-alkoksi-, halo-C1-C6-alkoksi-, hidroksi-C1-C6-alkil-, C1-C6-alkoksi-C1-C6-alkil-,
halo-C1-C6-alkoksi-C1-C6-alkil-, R8-(C1-C6-alkoksi)-, R8-O- , R8-S-, R8-S(=O)2-, (C3-C6-cikloalkil)-(CH2)n-O-;
R5b predstavlja skupinu odabranu od:
halo-, cijano-, nitro-, C1-C6-alkil-, halo-C1-C6-alkil-, C1-C6-alkoksi-, halo-C1-C6-alkoksi-, R8-O-, -C(=O)R8, -C(=O)O-R8, -N(H)C(=O)R8, -N(R7)C(=O)R8, -NR8R7, -NR7R7, -C(=O)N(H)R8, -C(=O)NR8R7, R8-S(=O)-, R8-S(=O)2-, -S(=O)(=NR7)R8;
Q1 predstavlja skupinu odabranu od: CH, C-(C1-C6-alkil), C-(C1-C6-alkoksi), C-halo;
Q2 predstavlja skupinu odabranu od: N, CH, C-R5c;
pri čemu R5c je odabran iz skupina koje se sastoje od:
halo-, cijano-, C1-C6-alkil-, C1-C6-alkoksi-, -N(H)C(=O)R7, -N(R7)C(=O)R7, -C(=O)N(H)R8, -C(=O)NR8R7, R8-S(=O)-, R8-S(=O)2-, -S(=O)(=NR7)R8;
Q3 predstavlja skupinu odabranu od: N, CH, C-R5c, pri čemu R5c je odabran iz skupina koje se sastoje od: halo-, cijano-, C1-C6-alkil-, C1-C6-alkoksi-, -N(H)C(=O)R7, -N(R7)C(=O)R7, -C(=O)N(H)R8, -C(=O)NR8R7, R8-S(=O)-, R8-S(=O)2-, -S(=O)(=NR7)R8;
R6 predstavlja skupinu odabranu od: C3-C6-cikloalkil-, 3- do 10-članog heterociklila-, aril-, heteroaril-, -(CH2)q-(C3-C6-cikloalkil), -(CH2)q-(3- do 10- članog heterociklila), -(CH2)q-aril, ili -(CH2)q-heteroaril;
pri čemu je navedena skupina proizvoljno supstituirana, jednom ili više puta, identično ili različito, sa supstituentom odabranim od:
halo-, hidroksi-, cijano-, nitro-, C1-C6-alkil-, halo-C1-C6-alkil-, C1-C6-alkoksi-, halo-C1-C6-alkoksi-, hidroksi-C1-C6-alkil-, C1-C6-alkoksi-C1-C6-alkil-, halo-C1-C6-alkoksi-C1-C6-alkil-;
n predstavlja cijeli broj 0, 1 ili 2;
q predstavlja cijeli broj 0, 1 ili 2;
ili njegov stereoizomer, tautomer, N-oksid, hidrat, solvat, ili njegova sol, ili smjesa istih.
3. Spoj prema zahtjevu 1 ili 2, naznačen time da:
R1 predstavlja fenil skupinu
- koja je supstituirana, jednom ili više puta, identično ili različito, sa supstituentom odabranim od:
-N(H)C(=O)R6, -C(=O)N(H)R6; te
- koja je proizvoljno supstituirana, jednom ili više puta, identično ili različito, sa supstituentom odabranim od:
halo-, C1-C6-alkil-, C1-C6-alkoksi-;
R3 i R4 predstavljaju atom vodika;
Q1 predstavlja CH;
Q2 predstavlja CH;
Q3 predstavlja CH ili N;
R5a predstavlja skupinu odabranu od:
halo-, C1-C6-alkil-,C1-C6-alkoksi-, halo-C1-C6-alkoksi-, (C3-C6-cikloalkil)-(CH2)n-O-;
R5b predstavlja skupinu odabranu od:
halo-, cijano-, C1-C6-alkoksi-, -N(H)C(=O)R8, -N(R7)C(=O)R8, -C(=O)N(H)R8, -C(=O)NR8R7, R8-S(=O)-, R8-S(=O)2-, -S(=O)(=NR7)R8;
R6 predstavlja skupinu odabranu od:
-(CH2)q-(C3-C6-cikloalkil) ili -(CH2)q-aril;
pri čemu navedena skupina je proizvoljno supstituirana, jednom ili više puta, identično ili različito, sa supstituentom odabranim od:
halo-, hidroksi-, cijano-, nitro-, C1-C6-alkil-, halo-C1-C6-alkil-, C1-C6-alkoksi-, halo-C1-C6-alkoksi-, hidroksi-C1-C6-alkil-, C1-C6-alkoksi-C1-C6-alkil-, halo-C1-C6-alkoksi-C1-C6-alkil-;
n predstavlja cijeli broj 0, 1 ili 2;
q predstavlja cijeli broj 1 ili 2;
ili njegov stereoizomer, tautomer, N-oksid, hidrat, solvat, ili njegova sol, ili smjesa istih.
4. Spoj prema bilo kojem zahtjevu od 1, 2 ili 3, naznačen time da:
R6 predstavlja skupinu odabranu od:
-CH2-(C3-C6-cikloalkil) ili -CH2-aril;
pri čemu je navedena skupina proizvoljno supstituirana, jednom ili više puta, identično ili različito, sa supstituentom odabranim od:
halo-, C1-C6-alkil-, halo-C1-C6-alkil-, halo-C1-C6-alkoksi-;
n predstavlja cijeli broj 0 ili 1;
q predstavlja cijeli broj 1;
ili njegov stereoizomer, tautomer, N-oksid, hidrat, solvat, ili njegova sol, ili smjesa istih.
5. Spoj prema zahtjevu 1, naznačen time da je odabran iz skupine koju čine:
N,N-dietil-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]-piridin-2-il]amino}-3-metoksibenzamid,
N-(4-{2-[(4-cijano-2-metoksifenil)amino][1,2,4]triazolo[1,5-a]piridin-6-il}-fenil)-2-(4-fluorofenil)acetamid,
N-(4-{2-[(2-etoksi-4-fluorofenil)amino][1,2,4]triazolo[1,5-a]piridin-6-il}fenil)-2-(4-fluorofenil)acetamid,
N-etil-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-metoksibenzamid,
N-tert-butil-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-metoksibenzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-N-(2-hidroksietil)-3-metoksibenzamid,
N-(2-etoksietil)-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo-[1,5-a]piridin-2-il]amino}-3-metoksibenzamid,
3-etoksi-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-N-(2-hidroksietil)benzamid,
3-etoksi-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-N-(1-hidroksi-2-metilpropan-2-il)benzamid,
3-etoksi-N,N-dietil-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]-triazolo[1,5-a]piridin-2-il]amino}benzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]-amino}-N-(2-hidroksietil)-3-(2,2,2-trifluoroetoksi)benzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-N-(2-hidroksi-2-metilpropil)-3-metoksibenzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-N-(1-hidroksi-2-metilpropan-2-il)-3-metoksibenzamid,
N-{2-[acetil(metil)amino]etil}-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)-[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-metoksi-N-metilbenzamid,
2-(4-fluorofenil)-N-[4-(2-{[2-metoksi-4-(metilsulfonil)fenil]amino}[1,2,4]-triazolo[1,5-a]piridin-6-il)fenil]acetamid,
3-etoksi-N-etil-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo-[1,5-a]piridin-2-il]amino}benzamid,
3-etoksi-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-N-(2-hidroksi-2-metilpropil)benzamid,
3-etoksi-N-etil-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]-triazolo[1,5-a]piridin-2-il]amino}-N-(2-metoksietil)benzamid,
3-etoksi-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-N-(2-hidroksietil)-N-metilbenzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]-amino}-3-metoksi-N-metil-N-[2-(metilamino)etil]benzamid,
N-tert-butil-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-(2,2,2-trifluoroetoksi)benzamid,
N,N-dietil-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-(2,2,2-trifluoroetoksi)benzamid,
N,N-dietil-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-propoksibenzamid,
3-(ciklopropilmetoksi)-N,N-dietil-4-{[6-(4-{[(4-fluorofenil)acetil]amino}-fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}benzamid,
N,N-dietil-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-izopropoksibenzamid,
N,N-dietil-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-(2-metoksietoksi)benzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]-amino}-3-(2,2,2-trifluoroetoksi)-N-(2,2,2-trifluoroetil)benzamid,
3-etoksi-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-N-[2-(metilsulfonil)etil]benzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-N-(2-hidroksi-2-metilpropil)-3-(2,2,2-trifluoroetoksi)benzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-metoksi-N-metilbenzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-N-(2-hidroksietil)-3-metoksibenzamid,
3-etoksi-4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)amino]-N-(2-hidroksietil)benzamid,
3-etoksi-4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)amino]-N-(1-hidroksi-2-metilpropan-2-il)benzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-N-(2-hidroksietil)-3-(2,2,2-trifluoroetoksi)benzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-N-(2-hidroksi-2-metilpropil)-3-metoksibenzamid,
N-(4-fluorobenzil)-4-(2-{[2-metoksi-4-(metilsulfonil)fenil]amino}[1,2,4]-triazolo[1,5-a]piridin-6-il)benzamid,
3-etoksi-4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)amino]-N-(2-hidroksi-2-metilpropil)benzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-N-(1-hidroksi-2-metilpropan-2-il)-3-metoksibenzamid,
N-{2-[acetil(metil)amino]etil}-4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}-[1,2,4]triazolo[1,5-a]piridin-2-il)amino]-3-metoksi-N-metilbenzamid,
N-(2-etoksietil)-4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)amino]-3-metoksibenzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-3-metoksi-N-metil-N-[2-(metilamino)etil]benzamid,
3-etoksi-4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)amino]-N-(2-hidroksietil)-N-metilbenzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-3-metoksi-N-metilbenzamid,
N-tert-butil-4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]-piridin-2-il)amino]-3-metoksibenzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-3-metoksi-N-[2-(metilsulfonil)etil]benzamid,
4-{2-[(2,4-dimetoksifenil)amino][1,2,4]triazolo[1,5-a]piridin-6-il}-N-(4-fluoro-benzil)benzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-3-metoksi-N-(2,2,2-trifluoroetil)benzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-N-(1-hidroksi-2-metilpropan-2-il)-3-(2,2,2-trifluoroetoksi)benzamid,
3-etoksi-4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)amino]-N-[2-(metilsulfonil)etil]benzamid,
N-etil-4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)amino]-3-metoksibenzamid,
N-tert-butil-3-etoksi-4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]-triazolo[1,5-a]piridin-2-il)amino]benzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-N-(2-hidroksi-2-metilpropil)-3-(2,2,2-trifluoroetoksi)benzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-3-(2,2,2-trifluoroetoksi)-N-(2,2,2-trifluoroetil)benzamid,
4-(2-{[4-(dimetilamino)-2-metilfenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)-N-(4-fluorobenzil)benzamid,
2-fluoro-N-(4-fluorobenzil)-4-[2-({4-[(1-hidroksi-2-metilpropan-2-il)karbamoil]-2-metoksifenil}amino)[1,2,4]triazolo[1,5-a]piridin-6-il]benzamid,
N-(4-fluorobenzil)-4-[2-({4-[(1-hidroksi-2-metilpropan-2-il)karbamoil]-2-metoksifenil}amino)[1,2,4]triazolo[1,5-a]piridin-6-il]-2-metilbenzamid,
2-kloro-N-(4-fluorobenzil)-4-[2-({4-[(1-hidroksi-2-metilpropan-2-il)karbamoil]-2-metoksifenil}amino)[1,2,4]triazolo[1,5-a]piridin-6-il]benzamid,
4-[(6-{4-[(ciklopropilmetil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-3-etoksi-N-etilbenzamid,
4-[(6-{4-[(ciklopropilmetil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-3-etoksi-N-etil-N-(2-metoksietil)benzamid,
4-[(6-{4-[(ciklopropilmetil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-3-etoksi-N-(2-hidroksietil)benzamid,
4-[(6-{4-[(ciklopropilmetil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)amino]-N-(2-hidroksietil)-3-(2,2,2-trifluoroetoksi)benzamid,
4-[(6-{4-[(ciklopropilmetil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-N-etil-3-(2,2,2-trifluoroetoksi)benzamid,
N-etil-4-[(6-{4-[(3-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)amino]-3-metoksibenzamid,
N-(4-fluorobenzil)-4-[2-({4-[(1-hidroksi-2-metilpropan-2-il)karbamoil]-2-metoksifenil}amino)[1,2,4]triazolo[1,5-a]piridin-6-il]-2-metoksibenzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]-amino}-3-metoksi-N-(2,2,2-trifluoroetil)benzamid,
N-[4-(2-{[2-etoksi-4-(metilsulfonil)fenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]-2-(4-fluorofenil)acetamid,
N-[4-(2-{[2-etoksi-4-(etilsulfonil)fenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]-2-(4-fluorofenil)acetamid,
2-(4-fluorofenil)-N-[4-(2-{[4-(metilsulfonil)-2-(2,2,2-trifluoroetoksi)fenil]-amino}[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]acetamid,
N-[4-(2-{[2-(difluorometoksi)-4-(metilsulfonil)fenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]-2-(4-fluorofenil)acetamid,
N-[4-(2-{[2-(difluorometoksi)-4-(etilsulfonil)fenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]-2-(4-fluorofenil)acetamid,
N-[4-(2-{[2-(ciklopropiloksi)-4-(metilsulfonil)fenil]amino}[1,2,4]triazolo[1,5-a]-piridin-6-il)fenil]-2-(4-fluorofenil)acetamid,
4-(2-{[2-etoksi-4-(metilsulfonil)fenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)-N-(4-fluorobenzil)benzamid,
4-(2-{[2-etoksi-4-(etilsulfonil)fenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)-N-(4-fluorobenzil)benzamid,
N-(4-fluorobenzil)-4-(2-{[4-(metilsulfonil)-2-(2,2,2-trifluoroetoksi)fenil]-amino}[1,2,4]triazolo[1,5-a]piridin-6-il)benzamid,
4-(2-{[2-(difluorometoksi)-4-(metilsulfonil)fenil]amino}[1,2,4]triazolo[1,5-a]-piridin-6-il)-N-(4-fluorobenzil)benzamid,
4-(2-{[2-(ciklopropiloksi)-4-(metilsulfonil)fenil]amino}[1,2,4]triazolo[1,5-a]-piridin-6-il)-N-(4-fluorobenzil)benzamid,
N-(4-fluorobenzil)-2-metil-4-(2-{[4-(metilsulfonil)-2-(2,2,2-trifluoroetoksi)-fenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)benzamid,
N-(4-fluorobenzil)-2-metoksi-4-(2-{[2-metoksi-4-(metilsulfonil)fenil]amino}-[1,2,4]triazolo[1,5-a]piridin-6-il)benzamid,
2-(2,4-difluorofenil)-N-[4-(2-{[2-metoksi-4-(metilsulfonil)fenil]amino}-[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]acetamid,
N-(2,4-difluorobenzil)-4-(2-{[2-metoksi-4-(metilsulfonil)fenil]amino}-[1,2,4]triazolo[1,5-a]piridin-6-il)benzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-metoksi-N-(2-metoksietil)benzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-metoksi-N,N-dimetilbenzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-metoksi-N-[2-(metilsulfonil)etil]benzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-metoksibenzamid,
N-(2-fluoroetil)-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]-triazolo[1,5-a]piridin-2-il]amino}-3-metoksibenzamid,
N-etil-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]-piridin-2-il]amino}-3-metoksi-N-metilbenzamid,
N-(2,2-difluoroetil)-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]-triazolo[1,5-a]piridin-2-il]amino}-3-metoksibenzamid,
N-[2-(dimetilamino)etil]-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]-triazolo[1,5-a]piridin-2-il]amino}-3-metoksi-N-metilbenzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]-amino}-3-metoksi-N-metil-N-(2,2,2-trifluoroetil)benzamid,
N-[2-(dimetilamino)etil]-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)-[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-metoksibenzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-N-(3-fluoropropil)-3-metoksibenzamid,
N-[4-(2-{[5-fluoro-2-metoksi-4-(metilsulfonil)fenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]-2-(4-fluorofenil)acetamid,
2-(4-fluorofenil)-N-[4-(2-{[2-metoksi-4-(metilsulfinil)fenil]amino}[1,2,4]-triazolo[1,5-a]piridin-6-il)fenil]acetamid,
N-[4-(2-{[5-fluoro-2-metoksi-4-(metilsulfinil)fenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]-2-(4-fluorofenil)acetamid,
N-[4-(2-{[4-(tert-butilsulfamoil)-2-metoksifenil]amino}[1,2,4]triazolo[1,5-a]-piridin-6-il)fenil]-2-(4-fluorofenil)acetamid,
2-(4-fluorofenil)-N-[4-(2-{[4-(2-hidroksipropan-2-il)-2-metoksifenil]amino}-[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]acetamid,
N-(4-{2-[(2,4-dimetoksifenil)amino][1,2,4]triazolo[1,5-a]piridin-6-il}fenil)-2-(4-fluorofenil)acetamid,
3-etoksi-N-etil-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo-[1,5-a]piridin-2-il]amino}-N-metilbenzamid,
N-[2-(dimetilamino)etil]-3-etoksi-4-{[6-(4-{[(4-fluorofenil)acetil]amino}-fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}benzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]-amino}-N-[2-(metilsulfonil)etil]-3-(2,2,2-trifluoroetoksi)benzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-N-(1-hidroksi-2-metilpropan-2-il)-3-(2,2,2-trifluoroetoksi)benzamid,
N-[2-(dimetilamino)etil]-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)-[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-(2,2,2-trifluoroetoksi)benzamid,
2-(4-fluorofenil)-N-[4-(2-{[4-(metilsulfinil)-2-(2,2,2-trifluoroetoksi)fenil]-amino}[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]acetamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-(trifluorometoksi)benzamid,
N-[4-(2-{[2-(difluorometoksi)-4-(propan-2-ilsulfonil)fenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]-2-(4-fluorofenil)acetamid,
N-[4-(2-{[2-(difluorometoksi)-4-fluorofenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]-2-(4-fluorofenil)acetamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-metilbenzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-3-metil-N-(2,2,2-trifluoroetil)benzamid,
N-(2-fluoroetil)-4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]-triazolo[1,5-a]piridin-2-il]amino}-3-metilbenzamid,
4-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-N,N,3-trimetilbenzamid,
2-(4-fluorofenil)-N-[4-(2-{[2-metil-4-(metilsulfonil)fenil]amino}[1,2,4]-triazolo[1,5-a]piridin-6-il)fenil]acetamid,
2-(4-fluorofenil)-N-[4-(2-{[2-metil-4-(metilsulfinil)fenil]amino}[1,2,4]-triazolo[1,5-a]piridin-6-il)fenil]acetamid,
2-(4-fluorofenil)-N-{4-[2-({2-metil-4-[(metilsulfonil)amino]fenil}amino)-[1,2,4]triazolo[1,5-a]piridin-6-il]fenil}acetamid,
2-(4-fluorofenil)-N-(4-{2-[(4-metoksi-2-metilfenil)amino][1,2,4]triazolo[1,5-a]piridin-6-il}fenil)acetamid,
N-[4-(2-{[4-(dimetilamino)-2-metilfenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]-2-(4-fluorofenil)acetamid,
N-etil-5-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-4-metilpiridine-2-karboksamid,
5-{[6-(4-{[(4-fluorofenil)acetil]amino}fenil)[1,2,4]triazolo[1,5-a]piridin-2-il]amino}-4-metil-N-(2,2,2-trifluoroetil)piridine-2-karboksamid,
N-[4-(2-{[2-fluoro-4-(metilsulfonil)fenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]-2-(4-fluorofenil)acetamid,
2-(4-fluoro-3-metilfenil)-N-[4-(2-{[2-metoksi-4-(metilsulfonil)fenil]-amino}[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]acetamid,
2-(4-klorofenil)-N-[4-(2-{[2-metoksi-4-(metilsulfonil)fenil]amino}-[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]acetamid,
N-[4-(2-{[2-metoksi-4-(metilsulfonil)fenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]-2-fenilacetamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-3-metoksibenzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-3-metoksi-N-(2-metoksietil)benzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-N-(2-fluoroetil)-3-metoksibenzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-3-metoksi-N,N-dimetilbenzamid,
N-(2,2-difluoroetil)-4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]-triazolo[1,5-a]piridin-2-il)amino]-3-metoksibenzamid,
N-[2-(dimetilamino)etil]-4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}-[1,2,4]triazolo[1,5-a]piridin-2-il)amino]-3-metoksibenzamid,
N-[2-(dimetilamino)etil]-4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}-[1,2,4]triazolo[1,5-a]piridin-2-il)amino]-3-metoksi-N-metilbenzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-N-(3-fluoropropil)-3-metoksibenzamid,
N-(4-fluorobenzil)-4-(2-{[2-metoksi-4-(metilsulfinil)fenil]amino}[1,2,4]-triazolo[1,5-a]piridin-6-il)benzamid,
4-(2-{[4-(tert-butilsulfamoil)-2-metoksifenil]amino}[1,2,4]triazolo[1,5-a]-piridin-6-il)-N-(4-fluorobenzil)benzamid,
N-(4-fluorobenzil)-4-(2-{[4-(2-hidroksipropan-2-il)-2-metoksifenil]amino}-[1,2,4]triazolo[1,5-a]piridin-6-il)benzamid,
N-[2-(dimetilamino)etil]-3-etoksi-4-[(6-{4-[(4-fluorobenzil)karbamoil]-fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)amino]benzamid,
3-etoksi-N-etil-4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)amino]-N-metilbenzamid,
3-etoksi-4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)amino]-N-(2-fluoroetil)benzamid,
N-[2-(dimetilamino)etil]-4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}-[1,2,4]triazolo[1,5-a]piridin-2-il)amino]-3-(2,2,2-trifluoroetoksi)benzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-N-(2-fluoroetil)-3-(2,2,2-trifluoroetoksi)benzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-3-(trifluorometoksi)benzamid,
4-(2-{[2-(difluorometoksi)-4-(etilsulfonil)fenil]amino}[1,2,4]triazolo[1,5-a]-piridin-6-il)-N-(4-fluorobenzil)benzamid,
4-(2-{[2-(difluorometoksi)-4-(propan-2-ilsulfonil)fenil]amino}[1,2,4]-triazolo[1,5-a]piridin-6-il)-N-(4-fluorobenzil)benzamid,
4-(2-{[2-(difluorometoksi)-4-fluorofenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)-N-(4-fluorobenzil)benzamid,
N-etil-4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)amino]-3-metilbenzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-3-metilbenzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-3-metil-N-(2,2,2-trifluoroetil)benzamid,
4-[(6-{4-[(4-fluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-N-(2-fluoroetil)-3-metilbenzamid,
N-(4-fluorobenzil)-4-(2-{[2-metil-4-(metilsulfonil)fenil]amino}[1,2,4]-triazolo[1,5-a]piridin-6-il)benzamid,
N-(4-fluorobenzil)-4-(2-{[2-metil-4-(metilsulfinil)fenil]amino}[1,2,4]-triazolo[1,5-a]piridin-6-il)benzamid,
N-(4-fluorobenzil)-4-[2-({2-metil-4-[(metilsulfonil)amino]fenil}amino)[1,2,4]-triazolo[1,5-a]piridin-6-il]benzamid,
N-(4-fluorobenzil)-4-{2-[(4-metoksi-2-metilfenil)amino][1,2,4]triazolo[1,5-a]piridin-6-il}benzamid,
4-[(6-{4-[(4-klorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-3-metoksi-N-(2,2,2-trifluoroetil)benzamid,
N-(4-klorobenzil)-4-(2-{[2-metoksi-4-(metilsulfonil)fenil]amino}[1,2,4]-triazolo[1, 5-a] piridin-6-il)benzamid,
N-(4-klorobenzil)-4-(2-{[2-metil-4-(metilsulfonil)fenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)benzamid,
N-(4-klorobenzil)-4-(2-{[2-metil-4-(metilsulfinil)fenil]amino}[1,2,4]-triazolo[1,5-a]piridin-6-il)benzamid,
4-(2-{[2-metoksi-4-(metilsulfonil)fenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)-N-(4-metilbenzil)benzamid,
N-(4-metilbenzil)-4-(2-{[2-metil-4-(metilsulfonil)fenil]amino}[1,2,4]-triazolo[1,5-a]piridin-6-il)benzamid,
N-(4-metilbenzil)-4-(2-{[2-metil-4-(metilsulfinil)fenil]amino}[1,2,4]-triazolo[1,5-a]piridin-6-il)benzamid,
4-[(6-{4-[(2,4-difluorobenzil)karbamoil]fenil}[1,2,4]triazolo[1,5-a]piridin-2-il)-amino]-3-metoksi-N-(2,2,2-trifluoroetil)benzamid,
N-(2,4-difluorobenzil)-2-metil-4-(2-{[4-(metilsulfonil)-2-(2,2,2-trifluoro-etoksi)fenil]amino}[1,2,4]triazolo[1,5-a]piridin-6-il)benzamid,
N-(4-fluorobenzil)-4-(2-{[4-(2-hidroksipropan-2-il)-2-metoksifenil]amino}-[1,2,4]triazolo[1,5-a]piridin-6-il)-2-metoksibenzamid,
2-(4-fluorofenil)-N-[4-(2-{[2-metoksi-4-(S-metilsulfonimidoil)fenil]amino}-[1,2,4]triazolo[1,5-a]piridin-6-il)fenil]acetamid,
N-(4-fluorobenzil)-4-(2-{[2-metoksi-4-(S-metilsulfonimidoil)fenil]amino}-[1,2,4]triazolo[1,5-a]piridin-6-il)benzamid,
2-(4-fluorofenil)-N-[4-(2-{[4-(hidroksimetil)-2-metoksifenil]amino}[1,2,4]-triazolo[1,5-a]piridin-6-il)fenil]acetamid,
i
N-(4-fluorobenzil)-4-(2-{[4-(hidroksimetil)-2-metoksifenil]amino}[1,2,4]-triazolo[1,5-a]piridin-6-il)benzamid,
ili njihov stereoizomer, tautomer, N-oksid, hidrat, solvat, ili njihova sol, ili smjesa istih.
6. Postupak za pripravu spoja opće formule (I) prema bilo kojem zahtjevu od 1 do 5, naznačen time da u postupku intermedijerni spoj opće formule (5) :
[image]
u kojoj R1, R3, R4, i R5 su kako je definirano za spojeve opće formule (I) u bilo kojem od zahtjeva 1 do 5,
je ostavljen da reagira s aril halogenidom opće formule (5a) :
R2-Y
(5a)
u kojoj je R2 kako je definirano za spojeve opće formule (I) u bilo kojem od zahtjeva 1 do 5, te Y predstavlja izlaznu skupinu, kao što je atom halogena ili na primjer trifluorometilsulfoniloksi ili nonafluorobutilsulfoniloksi skupina, te se tako dobiva spoj opće formule (I) :
[image]
u kojoj R1, R2, R3, R4, i R5 su kako je definirano za spojeve opće formule (I) u bilo kojem od zahtjeva 1 do 5.
7. Postupak za pripravu spoja opće formule (I) prema bilo kojem zahtjevu od 1 do 5, naznačen time da u postupku intermedijerni spoj opće formule (7) :
[image]
u kojoj R2, R3, R4, i R5 su kako je definirano za spojeve opće formule (I) u bilo kojem od zahtjeva 1 do 5, i R1a je arilnoj skupini na koju je vezan -NH2 supstituent,
omogućeno da reagira sa spojem opće formule:
R1b-X
(7a)
u kojoj R1b je -C(=O)R6, -C(=O)NR6R7, -S(=O)R6, -S(=O2R6, i X je odgovarajuće funkcionalna skupina, preko koje R1b se može vezati spoj R1b-X (7a), putem reakcije spajanja, kao što je na primjer amidna reakcija spajanja, na -NH2 supstituent vezan na arilnu skupina R1a spoja (7), čime zamjenjuje navedeni X s navedenim R1a, te se tako dolazi do spoja opće formule (I) :
[image]
u kojoj R1, R2, R3, R4, i R5 su kako je definirano za spojeve opće formule (I) u bilo kojem od zahtjeva 1 do 5.
8. Spoj prema bilo kojem zahtjevu od 1 do 5, ili stereoizomer, tautomer, N-oksid, hidrat, solvat, ili njihova sol, naročito njihova farmaceutski prihvatljiva sol, ili smjesa istih, naznačen time da je za uporabu za liječenje ili sprječavanje bolesti.
9. Spoj za uporabu prema zahtjevu 8, pri čemu navedena bolest je bolest nekontroliranog rasta stanica, proliferacije i/ili preživljavanja, neprikladan stanični imunološki odgovor, ili neprikladan stanični upalni odgovor, naročito u kojoj je nekontrolirani rast stanica, proliferacija i/ili preživljavanje, neprikladan stanični imunološki odgovor, ili neprikladan stanični upalni odgovor posredovan s MPS-1, posebno naročito kod kojeg je bolest nekontrolirani rast stanica, proliferacija i/ili preživljavanje, neprikladan stanični imunološki odgovor, ili neprikladan stanični upalni odgovor hematološki tumor, solidni tumor i/ili njihove metastaze, npr. leukemije i mijelodisplastični sindrom, maligni limfomi, tumori glave i vrata, uključujući tumore tumora mozga i metastaze na mozgu, tumori toraksa, uključujući tumore pluća ne-malih stanica i malih stanica, gastrointestinalni tumori, endokrini tumori, tumori dojke i drugi ginekološki tumori, urološki tumori uključujući tumori bubrega, mjehura i prostate, tumori kože, te sarkomi, i/ili njihove metastaze.
10. Farmaceutski pripravak naznačen time da sadrži spoj prema bilo kojem zahtjevu od 1 do 5, ili stereoizomer, tautomer, N-oksid, hidrat, solvat, ili njihovu sol, naročito njihovu farmaceutski prihvatljivu sol, ili njihovu smjesu, te farmaceutski prihvatljivo sredstvo za razrjeđivanje ili nosač.
11. Farmaceutska kombinacija naznačena time da sadrži:
- jedan ili više spojeva prema bilo kojem zahtjevu od 1 do 5, ili stereoizomer, tautomer, N-oksid, hidrat, solvat, ili njihovu sol, naročito njihove farmaceutski prihvatljive soli, ili njihova smjesa;
i
- jedno ili više sredstava odabranih od: taksana, kao što je Docetaksel, Paklitaksel, ili Taksol; epoilona, kao što je Iksabepilon, Patupilon, ili Sagopilon; Mitoksantron; Predinizolon; Deksametazon; Estramustin; Vinblastin; Vinkristin; Doksorubicin; Adriamicin; Idarubicin; Daunorubicin; Bleomicin; Etopozid; Ciklofosfamid; Ifosfamid; Prokarbazin; Melfalan; 5-Fluorouracil; Kapecitabin; Fludarabin; Citarabin; Ara-C; 2-kloro-2'-deoksiadenozin; Tiogvanin; anti-androgena, kao što je Flutamid, Ciproteron acetat, ili Bikalutamid; Bortezomib; derivata platine, kao što je Cisplatin, ili Karboplatin; Klorambucil; Metotreksat; te Rituksimab.
12. Uporaba spoja prema bilo kojem zahtjevu od 1 do 5, ili njegovog stereoizomera, tautomera, N-oksida, hidrata, solvata, ili njegove soli, naročito njegove farmaceutski prihvatljive soli, ili njihove smjese, naznačena time da je za pripravu medikamenta za sprječavanje ili liječenje bolesti.
13. Uporaba prema zahtjevu 12, naznačena time da navedena bolest je bolest nekontroliranog rasta stanica, proliferacije i/ili preživljavanja, neprikladan stanični imunološki odgovor, ili neprikladan stanični upalni odgovor, naročito u kojoj je nekontrolirani rast stanica, proliferacija i/ili preživljavanje, neprikladan stanični imunološki odgovor, ili neprikladan stanični upalni odgovor posredovan s Mps-1, posebno naročito kod kojeg je bolest nekontrolirani rast stanica, proliferacija i/ili preživljavanje, neprikladan stanični imunološki odgovor, ili neprikladan stanični upalni odgovor hematološki tumor, solidni tumor i/ili njihove metastaze, npr. leukemije i mijelodisplastični sindrom, maligni limfomi, tumori glave i vrata, uključujući tumore tumora mozga i metastaze na mozgu, tumori toraksa, uključujući tumore pluća ne-malih stanica i malih stanica, gastrointestinalni tumori, endokrini tumori, tumori dojke i drugi ginekološki tumori, urološki tumori uključujući tumori bubrega, mjehura i prostate, tumori kože, te sarkomi, i/ili njihove metastaze.
14. Spoj opće formule (7) :
[image]
naznačen time da su R2, R3, R4, i R5 kako je definirano za spojeve opće formule (I) u bilo kojem od zahtjeva 1 do 5, i R1a je aril skupina na koju je vezan -NH2 supstituent.
15. Uporaba spoja opće formule (5)
[image]
u kojem R1, R3, R4, i R5 su kako je definirano za spojeve opće formule (I) u bilo kojem od zahtjeva 1 do 5;
naznačena time da je za pripravu spoja opće formule (I) prema bilo kojem zahtjevu od 1 do 5.
16. Uporaba spoja opće formule (7) prema zahtjevu 14 naznačena time da je za pripravu spoja opće formule (I) prema bilo kojem zahtjevu od 1 do 5.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11163342 | 2011-04-21 | ||
EP11167872 | 2011-05-27 | ||
EP12721779.2A EP2699575B1 (en) | 2011-04-21 | 2012-04-16 | Triazolopyridines |
PCT/EP2012/056914 WO2012143329A1 (en) | 2011-04-21 | 2012-04-16 | Triazolopyridines |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20150517T1 true HRP20150517T1 (hr) | 2015-06-19 |
Family
ID=46124297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20150517TT HRP20150517T1 (hr) | 2011-04-21 | 2015-05-14 | Triazolopiridini |
Country Status (39)
Country | Link |
---|---|
US (1) | US20140120087A1 (hr) |
EP (1) | EP2699575B1 (hr) |
JP (1) | JP5989091B2 (hr) |
KR (1) | KR20140025470A (hr) |
CN (1) | CN103608350B (hr) |
AP (1) | AP3491A (hr) |
AR (1) | AR086191A1 (hr) |
AU (1) | AU2012244859B2 (hr) |
CA (1) | CA2833657A1 (hr) |
CL (1) | CL2013003044A1 (hr) |
CO (1) | CO6801751A2 (hr) |
CR (1) | CR20130539A (hr) |
CY (1) | CY1116439T1 (hr) |
DK (1) | DK2699575T3 (hr) |
DO (1) | DOP2013000244A (hr) |
EA (1) | EA023766B1 (hr) |
EC (1) | ECSP13013011A (hr) |
ES (1) | ES2539265T3 (hr) |
GT (1) | GT201300254A (hr) |
HK (1) | HK1190398A1 (hr) |
HR (1) | HRP20150517T1 (hr) |
HU (1) | HUE025496T2 (hr) |
IL (1) | IL228704A0 (hr) |
JO (1) | JO3040B1 (hr) |
MA (1) | MA35049B1 (hr) |
ME (1) | ME02143B (hr) |
MX (1) | MX348783B (hr) |
MY (1) | MY164939A (hr) |
PE (1) | PE20141351A1 (hr) |
PL (1) | PL2699575T3 (hr) |
PT (1) | PT2699575E (hr) |
RS (1) | RS54044B1 (hr) |
SA (1) | SA112330466B1 (hr) |
SG (1) | SG194003A1 (hr) |
SI (1) | SI2699575T1 (hr) |
TW (1) | TWI558703B (hr) |
UY (1) | UY34034A (hr) |
WO (1) | WO2012143329A1 (hr) |
ZA (1) | ZA201308707B (hr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20141066A1 (es) | 2011-04-21 | 2014-09-05 | Gilead Sciences Inc | Compuestos de benzotiazol |
UA112096C2 (uk) * | 2011-12-12 | 2016-07-25 | Байєр Інтеллектуал Проперті Гмбх | Заміщені триазолопіридини та їх застосування як інгібіторів ttk |
US9284323B2 (en) | 2012-01-04 | 2016-03-15 | Gilead Sciences, Inc. | Naphthalene acetic acid derivatives against HIV infection |
US9376392B2 (en) | 2012-01-04 | 2016-06-28 | Gilead Sciences, Inc. | 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS |
CA2867061A1 (en) | 2012-03-14 | 2013-09-19 | Bayer Intellectual Property Gmbh | Substituted imidazopyridazines |
EP2872506A1 (en) * | 2012-07-10 | 2015-05-20 | Bayer Pharma Aktiengesellschaft | Method for preparing substituted triazolopyridines |
WO2014020043A1 (en) | 2012-08-02 | 2014-02-06 | Bayer Pharma Aktiengesellschaft | Combinations for the treatment of cancer |
WO2014020041A1 (en) | 2012-08-02 | 2014-02-06 | Bayer Pharma Aktiengesellschaft | Combinations for the treatment of cancer |
CA2914516A1 (en) * | 2013-06-07 | 2014-12-11 | Bayer Pharma Aktiengesellschaft | Substituted triazolopyridines |
CA2914521A1 (en) * | 2013-06-07 | 2014-12-11 | Bayer Pharma Aktiengesellschaft | Substituted triazolopyridines having activity as mps-1 inhibitors |
BR112015030774A2 (pt) * | 2013-06-10 | 2017-07-25 | Bayer Pharma AG | novos compostos para o tratamento de câncer |
CN105283178A (zh) * | 2013-06-11 | 2016-01-27 | 拜耳制药股份公司 | 用于治疗癌症的包含mps-1激酶抑制剂和有丝分裂抑制剂的组合 |
DK3008062T3 (en) | 2013-06-11 | 2017-06-12 | Bayer Pharma AG | PRODRUG DERIVATIVES OF SUBSTITUTED TRIAZOLOPYRIDINES |
EP2860177A3 (en) | 2013-09-20 | 2015-06-10 | Bayer Intellectual Property GmbH | Synthesis of functionalized arenes |
CN107567503B (zh) | 2015-04-17 | 2022-03-22 | 荷兰转化研究中心有限责任公司 | 用于ttk抑制剂化疗的预后生物标记 |
UA125592C2 (uk) * | 2017-03-16 | 2022-04-27 | Джянгсу Хенгруй Медісін Ко., Лтд. | ПОХІДНА ГЕТЕРОАРИЛ[4,3-c]ПІРИМІДИН-5-АМІНУ, СПОСІБ ЇЇ ОТРИМАННЯ ТА ЇЇ МЕДИЧНІ ЗАСТОСУВАННЯ |
EP3956330A4 (en) | 2019-04-18 | 2023-01-18 | The Johns Hopkins University | SUBSTITUTED 2-AMINO-PYRAZOLYL-[1,2,4]TRIAZOLO[1,5A]PYRIDINE DERIVATIVES AND THEIR USE |
US11529350B2 (en) | 2019-07-03 | 2022-12-20 | Sumitomo Pharma Oncology, Inc. | Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
US5011472A (en) | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
JP2008509965A (ja) | 2004-08-17 | 2008-04-03 | ガルデルマ・リサーチ・アンド・デヴェロップメント | Ppar型受容体を活性化する新規な二芳香族化合物およびその化粧品組成物または医薬組成物における使用 |
US8883820B2 (en) * | 2006-08-30 | 2014-11-11 | Cellzome Ltd. | Triazole derivatives as kinase inhibitors |
CA2693232A1 (en) | 2007-07-18 | 2009-01-22 | Novartis Ag | Bicyclic heteroaryl compounds and their use as kinase inhibitors |
EA201000341A1 (ru) | 2007-08-23 | 2010-10-29 | Астразенека Аб | 2-анилинопурин-8-оны в качестве ингибиторов ttk/mps1 для лечения пролиферативных нарушений |
WO2009027283A1 (en) | 2007-08-31 | 2009-03-05 | Merck Serono S.A. | Triazolopyridine compounds and their use as ask inhibitors |
GB0719803D0 (en) * | 2007-10-10 | 2007-11-21 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
AU2008328882A1 (en) * | 2007-11-27 | 2009-06-04 | Cellzome Limited | Amino triazoles as PI3K inhibitors |
KR20110116160A (ko) | 2009-02-13 | 2011-10-25 | 포비어 파마수티칼스 | 카이네이스 저해제로서의 〔1,2,4〕트리아졸로〔1,5-a〕피리딘 |
ES2547328T3 (es) | 2009-04-29 | 2015-10-05 | Bayer Intellectual Property Gmbh | Imidazoquinoxalinas sustituidas |
JP5728683B2 (ja) | 2009-09-04 | 2015-06-03 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH | チロシンスレオニンキナーゼ阻害剤としての置換アミノキノキサリン |
EP2343297A1 (en) * | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Triazolopyridines |
UY33452A (es) * | 2010-06-16 | 2012-01-31 | Bayer Schering Pharma Ag | Triazolopiridinas sustituidas |
-
2012
- 2012-04-16 MX MX2013012289A patent/MX348783B/es active IP Right Grant
- 2012-04-16 SI SI201230220T patent/SI2699575T1/sl unknown
- 2012-04-16 JP JP2014505584A patent/JP5989091B2/ja not_active Expired - Fee Related
- 2012-04-16 MA MA36344A patent/MA35049B1/fr unknown
- 2012-04-16 MY MYPI2013701964A patent/MY164939A/en unknown
- 2012-04-16 US US14/113,017 patent/US20140120087A1/en not_active Abandoned
- 2012-04-16 HU HUE12721779A patent/HUE025496T2/en unknown
- 2012-04-16 PT PT127217792T patent/PT2699575E/pt unknown
- 2012-04-16 PE PE2013002378A patent/PE20141351A1/es not_active Application Discontinuation
- 2012-04-16 WO PCT/EP2012/056914 patent/WO2012143329A1/en active Application Filing
- 2012-04-16 SG SG2013073044A patent/SG194003A1/en unknown
- 2012-04-16 ME MEP-2015-80A patent/ME02143B/me unknown
- 2012-04-16 CN CN201280030682.XA patent/CN103608350B/zh not_active Expired - Fee Related
- 2012-04-16 AP AP2013007182A patent/AP3491A/xx active
- 2012-04-16 ES ES12721779.2T patent/ES2539265T3/es active Active
- 2012-04-16 EP EP12721779.2A patent/EP2699575B1/en active Active
- 2012-04-16 EA EA201301181A patent/EA023766B1/ru not_active IP Right Cessation
- 2012-04-16 AU AU2012244859A patent/AU2012244859B2/en not_active Ceased
- 2012-04-16 CA CA2833657A patent/CA2833657A1/en not_active Abandoned
- 2012-04-16 KR KR1020137030546A patent/KR20140025470A/ko not_active Application Discontinuation
- 2012-04-16 PL PL12721779T patent/PL2699575T3/pl unknown
- 2012-04-16 DK DK12721779.2T patent/DK2699575T3/da active
- 2012-04-16 RS RS20150345A patent/RS54044B1/en unknown
- 2012-04-18 JO JOP/2012/0093A patent/JO3040B1/ar active
- 2012-04-18 SA SA112330466A patent/SA112330466B1/ar unknown
- 2012-04-20 AR ARP120101355A patent/AR086191A1/es active Pending
- 2012-04-20 UY UY0001034034A patent/UY34034A/es not_active Application Discontinuation
- 2012-04-20 TW TW101114259A patent/TWI558703B/zh not_active IP Right Cessation
-
2013
- 2013-10-03 IL IL228704A patent/IL228704A0/en unknown
- 2013-10-18 GT GT201300254A patent/GT201300254A/es unknown
- 2013-10-21 CL CL2013003044A patent/CL2013003044A1/es unknown
- 2013-10-21 CR CR20130539A patent/CR20130539A/es unknown
- 2013-10-21 DO DO2013000244A patent/DOP2013000244A/es unknown
- 2013-10-21 CO CO13248763A patent/CO6801751A2/es active IP Right Grant
- 2013-11-05 EC ECSP13013011 patent/ECSP13013011A/es unknown
- 2013-11-20 ZA ZA2013/08707A patent/ZA201308707B/en unknown
-
2014
- 2014-04-15 HK HK14103581.3A patent/HK1190398A1/zh not_active IP Right Cessation
-
2015
- 2015-05-14 HR HRP20150517TT patent/HRP20150517T1/hr unknown
- 2015-06-12 CY CY20151100512T patent/CY1116439T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20150517T1 (hr) | Triazolopiridini | |
HRP20141093T1 (hr) | Triazolopirimidini | |
JP2014511887A5 (hr) | ||
HRP20171248T1 (hr) | Amino-supstituirani imidazopiridazini | |
CN109641854B (zh) | 整合应激通路的调节剂 | |
WO2020081880A1 (en) | Compositions targeting senescent cells and the uses thereof | |
TWI689502B (zh) | 新穎經取代吲唑、其製法、包含其之醫藥製劑及其製備藥劑之用途 | |
ES2373688T3 (es) | Pirrolo[2,3-b]piridinas y pirrolo[2,3-b]pirimidinas sustituidas con heteroarilo como inhibidores de quinasas janus. | |
CN112204009A (zh) | 整合应激通路的调节剂 | |
JP7258748B2 (ja) | サイクリン依存性キナーゼ12(cdk12)の阻害剤およびその使用 | |
DK2464356T3 (en) | Sigma ligands for the prevention or treatment of pain induced by chemotherapy | |
EP3333169A1 (en) | Pyrazolopyrimidine jak inhibitor compounds and methods | |
JP2014513704A5 (hr) | ||
CN103492370A (zh) | 取代的二氨基甲酰胺和二氨基甲腈嘧啶,其组合物,和用其治疗的方法 | |
UA79470C2 (en) | Indole, azaindole and related heterocyclic 4-alkenylpiperidine amides | |
JP2010538094A5 (hr) | ||
JP2014532716A5 (hr) | ||
WO2007091107A1 (en) | Treatment of duchenne muscular dystrophy | |
EA032639B1 (ru) | Гидрохлоридные соли n-(цианометил)-4-(2-(4-морфолинофениламино)пиримидин-4-ил)бензамида | |
PT3004112T (pt) | Derivados de pirazolo-pirrolidin-4-ona e sua utilização no tratamento de doença | |
JP2013523814A5 (hr) | ||
US20210000825A1 (en) | Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof | |
WO2015134171A1 (en) | Heteroarylamide inhibitors of tbk1 | |
JP2016508135A5 (hr) | ||
CA2944462A1 (en) | Novel hdmx inhibitors and their use for cancer treatment |